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ABSTRACT 
Title: The Socio-Economic and Behavioural Factors Associated with Poor Glycaemic 
Control Among Adult Type 2 Diabetic Patients Attending the Outpatient Diabetes Clinic in 
Tertiary Hospitals in Abuja, Nigeria. 
E.C. Igboerika 
MPH Minithesis, School of Public Health, University of the Western Cape 
 
Background: The prevalence of diabetes in Africa has been on the increase. A prevalence of 1%-
10% has been reported by different authors in different regions in Nigeria. The International 
Diabetes Federation estimates that 1.9% of Nigerians are diabetic and most of them have 
complications at the time of diagnosis. Laboratory measurement of Glycosylated hemoglobin 
(HbA1c) is the method of choice for monitoring glycaemic control but due to its cost and limited 
availability, most developing countries use fasting plasma glucose (FPG) measurement (which is 
less reliable) to assess glycaemic control. Most diabetic patients in Nigeria have poor glycaemic 
control and several factors have been implicated especially socio-economic, behavioral and 
treatment-related factors. Understanding the reasons for poor glycaemic control is essential in 
order to reduce the rate of diabetes complications.  
Aim: To determine the prevalence of poor glycaemic control and analyze the socio-economic and 
behavioural factors influencing glycaemic control of outpatient adult type 2 diabetic patients in 
tertiary hospitals in Abuja, Nigeria. 
Methodology: A cross-sectional analytical study involving 327 type 2 diabetic patients aged 
between 20 and 79 years on follow up outpatient visits at tertiary hospitals in Abuja (National 
Hospital and University of Abuja Teaching Hospital) between December 2016 to March, 2017. A 
semi-structured questionnaire was used to collect data from the participants on their socio-
economic attributes and behaviours. The level of glycaemic control was assessed through the 
patient’s treatment record review. The data was entered into the Microsoft Excel 2013 package 
and analysis of the data was done using Epi Info 7 statistical software. 
Findings: The mean age of the patients sampled was 54 years and 60% of them were females. 
Majority of the patients (47%) were middle income earners and have completed tertiary education 
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(56%). Most of the patients were employed (63%) and about three quarter of them resided in urban 
settings. Just above 50% of the patients had a positive family history. Two thirds of the diabetic 
patients sampled were being treated with only oral medications while 8% are on insulin-only 
treatment. Twenty-eight percent are on a combination regimen of oral medications and insulin 
injection. Seventy-five percent of the patients had other comorbidities especially hypertension and 
dyslipidemia. The average pill load of the patients on oral medications was 4.8 tablets per day. The 
mean BMI and waist circumference of the study population was 28.9 kg/m2 and 97.6cm 
respectively. About 35% of the patients were physically active and only 34% of the respondents 
had done daily self-monitoring of blood glucose in the past one week. The level of satisfaction 
was high with 91% of the patients being happy with the services they received from their healthcare 
provider. Fifty-three percent of the patients had poor glycaemic control and the mean HbA1c and 
FPG of the respondents were 7.6% and 142 mg/dl respectively. 
The associations between glycaemic control and the different socio-demographic variables were 
not statistically significant but the trends were consistent with previous studies done in similar 
settings. Patients at extremes of ages had the highest rate of poor glycaemic control (20-29: 67% 
and 70-79: 70%). Poor glycaemic control was more prevalent in males (54% vs 52% in females), 
married (54% vs 47% in ‘not married’), rural dwellers (55% vs 52% in urban dwellers), and 
patients without family history of diabetes (56% vs 50% in those with family history). Patients 
with high income, tertiary education and employment had the worst level of glycaemic control 
compared with those with lower income, less education and unemployed. 
Behavioural and lifestyle factors also influenced glycaemic control amongst the patients sampled. 
Dietary habits emerged as the most significant factor that affects glycaemic control in diabetic 
patients. Patients with poor dietary habits had worse glycaemic control compared to those who eat 
healthy. This was found to be statistically significant across several dietary behaviours that were 
assessed. Although not statistically significant, physical inactivity, obesity and frequent self-
monitoring of blood glucose were found to be risk factors of poor glycaemic control. 
Patients on combination therapy of insulin and oral medications had the highest rate of poor 
glycaemic control (65%) compared to insulin-only (48%), oral-only (49%) and non-
pharmacological (40%) group. Patients taking 5 or less number of tablets per day had higher rate 
of poor glycaemic control (55%) compared to those on more than 5 tablets per day (48%). Patients 
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who are dissatisfied with the quality of service of their healthcare provider were also found to have 
poorer glycaemic control (70% vs 51% in the ‘satisfied’ group). This difference was statistically 
significant. 
Conclusion: Socio-demographic, behavioural and treatment related-factors affect glycaemic 
control of adult type 2 diabetic patients but the most significant influence on glycaemic control is 
behavioural/lifestyle factors. Patients with poor dietary habits had the worst glycaemic control. 
Physical inactivity, obesity, extremes of age, male gender, being married, high income, being 
employed, completing tertiary education, frequent self-monitoring of blood glucose, combination 
therapy with oral medications and insulin and being dissatisfied with the healthcare provider were 
all seen to be associated with poorer glycaemic control. Collaborative efforts should therefore be 
made by political leaders, healthcare providers, health promoters and most importantly the patient 
in ensuring that the conducive environment that will make it easier for the patients to adopt 
healthier lifestyles (e.g. healthy eating, physical activity) is created. Patients should also make 
sincere efforts in being completely involved in their management and also devise means to 
improve adherence not only to medications but also to lifestyle recommendations. 
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CHAPTER 1 INTRODUCTION 
Diabetes mellitus (DM) is a chronic noncommunicable disease (NCD) characterized by persistent 
high blood glucose in which the body cannot produce enough insulin (a hormone that regulates 
blood glucose) or cannot use it effectively (Masharani, 2017: 1210). There are 3 main types of DM 
i.e. type 1, type 2 and gestational diabetes.  For the purpose of this research the focus will be on 
type 2 diabetes because it constitutes about 90% of all diabetes cases (World Health Organisation 
(WHO), 2017). 
Type 2 diabetes was previously regarded as a disease of affluence but prevalence data over the 
past decades have shown remarkable increase in the incidence of diabetes in traditionally poor 
communities and in Low and Middle-Income Countries (LMICs) (International Diabetes 
Federation (IDF), 2015). Globally, an estimated 415 million adults have diabetes and 75% of these 
live in LMICs (IDF, 2015). 
Despite the higher prevalence of diabetes in sub-Saharan Africa, the region accounts for only 0.5% 
of the global health expenditure on diabetes (IDF, 2015). According to the IDF, African countries 
spent the least amount on diabetes healthcare in comparison with other regions despite bearing the 
greatest burden. This has further stretched the health system which has been crippled by 
communicable diseases, HIV/AIDS and violence (Boutayeb & Boutayeb, 2005).  
Local studies report a diabetes prevalence between 2% and 10% (Chinenye et al, 2012; Enang et 
al, 2014; Ogbera & Ekpebegh, 2014; Ejike, Uka & Nwachukwu, 2015; Olayemi & Osazuwa, 2016) 
but the IDF 2015 diabetes atlas estimates that 1.9% (1.4% to 4.6%) of Nigerians aged between 20-
79 years are diabetic. The major challenges faced in the provision of care of diabetics in Nigeria 
are centered around late detection and/or misdiagnosis and exorbitant cost of diabetes 
management. Poverty, ignorance, attribution of disease symptoms to myths and deities, lack of 
basic infrastructure and poor access to health care are some of the factors that have increased the 
risk of misdiagnosis of diabetes, late detection and early onset of complications amongst diabetic 
patients in Nigeria (Oguejiofor, Odenigbo & Onwukwe, 2014).  
Many diabetic patients in Nigeria simply cannot afford to pay for adequate care of their ailment 
because diabetes management is quite expensive. The costs of treating diabetes are incurred from 
http://etd.uwc.ac.za
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treating the disease itself, treating the possible complications and treating other diseases where 
diabetes is a risk factor. This burden is worsened when we consider the reduction in the economic 
productivity of these patients and the effects this may have in their family. The above-mentioned 
factors have contributed to the high prevalence of complications in Nigerian diabetic patients 
(Chinenye et al, 2012) due to their poor level of glycaemic control (HbA1c greater than 7% and/or 
FPG persistently greater than 126mg/dl) (American Diabetic Association (ADA), 2017).  
Twenty-four percent of patients who had stroke in Abuja, Nigeria were found to be diabetic (Alkali 
et al, 2013) and diabetic foot disease is the major indication for limb amputation in National 
Hospital, Abuja (Umaru, Madubueze, Alada & Onu, 2015). Several factors have been implicated 
in the high prevalence of poor glycaemic control among Nigerian diabetic patients but socio-
economic and behavioural factors are the most incriminated (Enwere, Salako & Falade, 2006; 
Yusuff, Obe & Joseph, 2008; Adisa, Alutundu & Fakeye, 2009; Adibe, Aguwa, Ukwe, Okonta & 
Udeogaranya, 2009; Adisa et al, 2011; Pascal et al, 2015). Diabetes treatment is unattainable for 
most diabetic patients in Nigeria in the absence of health insurance and with 33% of the population 
living below the poverty line.   
Most studies select certain socio-economic variables (often one or two) to establish an association 
between them and poor glycaemic control but this study aims to evaluate a wider range of social, 
economic and demographic factors.  Some lifestyle factors that have been implicated in poor 
glycaemic control are lack of physical activity, dietary intake patterns and attitude towards self-
monitoring of blood glucose.  Nigerians have abandoned their traditional staple foods (mainly 
roots and tubers) and adopted western-style diets with high glycaemic index like refined white 
rice, pastries (Mattei et al, 2015), sugary beverages and red meat (Harvard School of Public Health 
(HSPH), 2016). 
In addition to behaviour and lifestyle, several treatment-related factors also play a role in achieving 
good glycaemic control: correct choice of drugs, correct dosage of drugs and patients’ adherence 
to medications and recommendations.  
The only effective way to reduce complications from diabetes is to maintain good glycaemic 
control throughout the duration of the disease. It is therefore very important to understand the 
reasons why diabetic patients have poor glycaemic control. This is the essence of this study. 
http://etd.uwc.ac.za
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CHAPTER 2 LITERATURE REVIEW 
2.1 What is Diabetes? 
Diabetes mellitus (DM) is a ‘syndrome of chronic hyperglycaemia (persistently elevated blood 
glucose) due to relative insulin deficiency, resistance or both’ (Masharani, 2017; Gale & Anderson, 
2017). It affects about 415 million people worldwide and it is estimated that 642 million people 
will be diabetic by 2040 (IDF, 2015). To diagnose someone with diabetes, the following WHO 
criteria must be met: fasting plasma glucose >126mg/dl or random plasma glucose >200mg/dl (one 
abnormal value if patient is symptomatic, otherwise two abnormal values) and a HbA1c >6.5% 
(Gale & Anderson, 2017). 
Diabetic patients have a long latent period during which they show no symptoms and are mostly 
unaware that they have the disease (Gale & Anderson, 2017). When symptoms develop, the initial 
classic triad of symptoms include polyuria, weight loss and thirst. Other subacute symptoms 
include lack of energy, visual blurring or fungal infections. Many diabetics develop complications 
like retinopathy, nephropathy, neuropathy, erectile dysfunction and arterial disease (Gale & 
Anderson, 2017) if their blood glucose level is not adequately controlled. 
2.2 Glycaemic Control 
Glycaemic control is the regulation and maintenance of blood glucose levels within normal ranges. 
Achieving good glycaemic control is the primary treatment target for all diabetic patients (IDF, 
2015; ADA, 2017) and it entails preventing high blood glucose (hyperglycaemia) and low blood 
glucose (hypoglycaemia). Diabetic patients with fasting plasma glucose (FPG) consistently less 
than 126 mg/dl or a HbA1c less than 7% are said to have good glycaemic control (WHO, 2011; 
IDF, 2015). Poor glycaemic control leads to poor quality of life (Kamarul Imran et al, 2010), 
frequent hospital admissions, more expenses on treatment (Testa & Simonson, 1998), more 
complications and higher mortality rates. Good glycaemic control helps to reduce the cost of 
diabetes management (Roebuck et al, 2011) by reducing the rate of complications (Agboola-Abu, 
Ohwovoriole & Akinlade, 2000; Zimmet, 2003; Wild et al, 2004;) and mortality (Diabetes Control 
and Complications Trial [DCCT] Research Group, 1993; United Kingdom Prospective Diabetes 
Study [UKPDS] Group, 1998; Nathan et al, 2005; Adebisi et al, 2009).  
http://etd.uwc.ac.za
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2.2.1 Monitoring of Glycaemic Control 
Glycaemic control can be monitored using intermittent fasting plasma glucose (FPG) measurement 
and the measurement of Glycosylated haemoglobin (HbA1c) (Saudek, Derr & Kalyani, 2006; 
Rodbard et al, 2009; ADA, 2017). The FPG is simple to perform, cheap and widely available 
(WHO, 2011; Pascal et al, 2015; Harris, 1993). However, its values represent the blood glucose 
level at the point of testing and are affected by day-to-day fluctuations, exercise and recent food 
or drug intake. It is therefore not a reliable proof of adequate glycaemic control (Dailey, 2007). 
The cost-friendliness and wide availability of FPG in developing countries makes it a preferred 
choice for monitoring glycaemic control (Adisa et al, 2011; Pascal et al, 2015). Generally, patients 
whose FPG are below 126mg/dl during follow up can be said to have adequate glycaemic control 
(WHO & IDF, 2006). However, it is important to note that several studies have used cut-off points 
lower than this (UKPDS Group, 1998; Adisa et al, 2011; Pascal et al, 2015). 
HbA1c is regarded as the gold standard for monitoring glycaemic control because of its ability to 
indicate sustained hyperglycaemia-which is a major trigger for complications. HbA1c gives an 
overview of the average plasma glucose in the preceding three months (Adebisi, Oghagbon, 
Akande & Olarinoye, 2009; ADA, 2011; WHO, 2011), it does not fluctuate with time of day, 
exercise, food or drug ingestion and is a more reliable predictor of glycaemic control (DCCT 
Research Group, 1993; UKPDS Group, 1998). The normal HbA1c levels for normal individuals 
ranges from 4.5% to 6%. The American Diabetes association (ADA) accepts any value <7.0% as 
normal (ADA, 2017). For most persons who have been previously diagnosed with diabetes, an 
HbA1c of 7% is often the treatment target. Consequentially, the cutoff point for poor vs. good 
glycaemic control in most studies is 7% (Al-Rasheedi, 2014; Khattab et al, 2010). In managing a 
diabetic patient, achieving a 1% absolute reduction in HbA1c reduces the risk of a major 
cardiovascular event (by 15% to 20%) and microvascular complications (by 37%) (Sigal et al, 
2007). The ADA (2017) recommends that the HbA1c test is performed at least two times in a year 
in patients who are meeting treatment goals and have stable glycaemic control and quarterly in 
patients whose treatment regimen has changed or are not meeting glycaemic targets. Patients who 
have the opportunity of point-of-care HBA1c test are more likely to benefit from timely treatment 
adjustments (ADA, 2017) 
http://etd.uwc.ac.za
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2.3 Causes of Poor Glycaemic Control 
The causes of poor glycaemic control can be broadly classified into socio-economic, 
psychological, healthcare provider related causes, health system causes, lifestyle/behavioural 
factors, disease related causes and treatment related causes (Delamater, 2006).  
2.3.1 Socio-Economic Factors 
Socio-economic factors play the most significant role in the level of glycaemic control amongst 
diabetic patients (Shilubane, 2010). Poor glycaemic control is highest among individuals with low 
income (Delamater, 2006), financial constraints (Adisa et al, 2011; Pascal et al, 2015), no formal 
education and no employment (Almutairi, Said & Zainuddin, 2013). Individuals who are socio-
economically disadvantaged are not able to buy their medications, do their laboratory 
investigations or keep up with their follow-up appointments. They cannot afford healthy diets and 
often lack the means to visit recreation or sports parks for physical activities. It is therefore more 
difficult for this group of persons to maintain a good level of glycaemic control. 
Adisa et al (2011), in their cross-sectional study of type 2 diabetic patients attending the diabetes 
clinic in a tertiary hospital in Nigeria, reported that 34.4% of the respondents identified financial 
constraints as the major reason for not adhering to their medications. In another study, 59% of the 
diabetic patients were non-adherent to their medications due to lack of finance (Yusuff, Obe & 
Joseph, 2008). High cost of diabetes medications has been implicated by a large proportion of 
diabetic patients (35.5% [Adisa, Alutundu & Fakeye, 2009] and 52.2% [Enwere, Salako & Falade, 
2006]) as a major cause of nonadherence. Most of the diabetes medications are imported and this 
further worsens the plight of Nigerian diabetics (Adibe, Aguwa, Ukwe, Okonta & Udeogaranya, 
2009). 
Socially deprived diabetics have been shown to have a higher mortality than those who are not 
deprived (Robinson, Lloyd & Stevens, 1998). The mortality rate for type 2 diabetics is higher for 
those of lower social class vs higher social class (Odds Risk(OR) 2.0). The mortality rate was three 
times higher for patients who left school before the age of 16 compared to those who left school 
at or above 16 years of age. Unemployed diabetics had a higher mortality rate than employed 
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patients (OR 2.88) (Robinson, Lloyd & Stevens, 1998). These higher rates of mortality were linked 
with a higher rate of complication in the disadvantaged populations. In a cohort of type 2 diabetics 
in London, James et al (2012) reported a persistently worse glycaemic control despite more 
intensive treatment amongst socially disadvantaged populations. The rate of improvement of the 
control was even less in these populations. At the beginning of the study, 44% of the White 
population had a good glycaemic control (HbA1c < 7.5%) while 38% of the Black 
African/Caribbean population had a similar level of control. These figures improved to 56% and 
53% respectively at the end of the 5-year study period. 
Diabetes is an expensive disease to manage. It is therefore understandable that patients who are 
financially and socially constrained might not be able to meet up with the financial commitment 
of a proper diabetes management plan. An efficient social health insurance scheme would have 
been an easy way out of the quagmire but such a system does not exist in the Nigerian healthcare 
system. Only 5% of Nigerians have any form of prepaid health care through social or voluntary 
private insurance (Onwujekwe, Hanson & Uzochukwu, 2012). Most Nigerian patients buy their 
drugs, pay for laboratory tests and consultation fees out-of-pocket. In a country with high level of 
poverty and a minimum wage that cannot provide enough food or shelter, it is clear that health 
care will definitely not be adequate. The chronic nature of type 2 diabetes further complicates this 
scenario because these patients spend their entire lifetime buying drugs, attending follow ups and 
doing laboratory investigations. Type 2 diabetic patients without insurance for self-monitoring 
supplies often have significantly worse glycaemic control (Bowker et al, 2004; Karter et al, 2000). 
In a Canadian study, the average HbA1c of the insured patients was 7.1% and uninsured patients 
had an average HbA1c of 7.4% (Bowker et al, 2004). Bowker et al in their cross-sectional study, 
sampled patients at community pharmacies in Alberta and Saskatchewan provinces in Western 
Canada with an initial hypothesis that insured patients were more likely to self-monitor their blood 
glucose and therefore have a better glycaemic control. This hypothesis was confirmed in their 
study. Forty-one percent of their subjects had a form of health insurance, in sharp contrast to the 
Nigerian setting.  
Saydah et al (2007) did not find any association between socio-economic status (using only 
education and poverty status) and glycaemic control of patients in the United States. Saydah et al, 
having recognized the incompleteness of the measures of socio-economic status in the NHANES 
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1999-2002 questionnaire (which they used in their survey), adjusted for other probable socio-
economic factors that can influence glycaemic control. After the adjustment, obesity, healthcare 
access and utilization, diabetes treatment and racial/ethnic differences remained significant 
influences on glycaemic control in the surveyed patients.  
2.3.2 Lifestyle/Behavioural Factors 
Behavioural factors like dietary pattern, physical activity level, body weight, alcohol and smoking 
influence the glycaemic control in type 2 diabetic patients. Close monitoring of the diet and 
involvement in regular physical activities promote good glycaemic control (Almutairi, Said & 
Zainuddin, 2013). This is evidenced in the U.K. Prospective Diabetes Study (UKPDS) in which 
newly diagnosed type 2 diabetics underwent 3 months’ dietary treatment which reduced their 
HbA1c from approximately 9% to 7%. Nutrition therapy is a key component of American Diabetes 
Association’s guidelines on lifestyle management of diabetes patients (ADA, 2017). While the 
choice of diet remains the most challenging component of diabetes management, the lack of a one-
size fits all eating pattern makes diet a recurrent topic in improvement of glycaemic control in 
patients with diabetes (ADA, 2017). Dietary patterns of diabetic patients should be tailored to 
personal and cultural food preferences and the calorie needs of the patient (Ley, Hamdy, Mohan 
& Hu, 2014). In order to achieve glycaemic control, diets rich in wholegrains, fruits, vegetables 
and nuts have been shown to be effective in the nutritional management of diabetes (Ley, Hamdy, 
Mohan & Hu, 2014). Similarly, the blood glucose and lipid levels of diabetic patients are better 
controlled with diets lower in refined grains, red or processed meat and sugar-sweetened beverages 
(Ley, Hamdy, Mohan & Hu, 2014). 
An alternative approach to consider diet in diabetes is to consider food patterns rather than isolated 
food items. The relationship between different food patterns and glycaemic control have been 
widely studied. The Mediterranean, DASH (Dietary Approaches to Stop Hypertension) and 
‘moderately low carbohydrate’ diets are some of the food patterns that have been studied and their 
beneficial effects on glycaemic control was evident (Ley, Hamdy, Mohan & Hu, 2014). 
Mediterranean diet entails the high consumption of minimally processed plant-based foods, low-
to-moderate consumption of dairy products, fish and poultry, low consumption of red meat, and 
low-to-moderate consumption of wine with meals. The major source of fat in the Mediterranean 
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diet is olive oil. In addition to the role of Mediterranean diet in improving glycaemic control, 
studies have shown that patients on such diet have also an improved insulin sensitivity and a 
reduced cardiovascular risk (Shai et al, 2008; Esposito et al, 2009, Esposito et al, 2010 & Estruch 
et al, 2013).  
The DASH diet is rich in fruits and vegetables, low-fat dairy products, wholegrains, poultry, fish 
and nuts but is low in saturated fat, red meat, sweets, sugar containing beverages and sodium. The 
DASH diet has been shown to be beneficial in the control of glycaemia in patients with diabetes 
and the reduction of cardiovascular risk factors (Azadbakht et al, 2011). 
The ‘moderately low carbohydrate’ diet involves the reduction of the amount of carbohydrate in 
the diet and the increase in the quantity of fats and protein from animal or plant food sources. This 
form of diet has been shown to improve glycaemic control, reduce blood lipids, led to greater 
weight loss in diabetic patients in comparison to conventional control diets (Ajala, English & 
Pinkney, 2013). 
Vegetarian and vegan diets did not show consistently positive effects on glycaemic control or the 
cardiovascular risk reduction in diabetic patients (Barnard et al, 2009; Ajala, English & Pinkney, 
2013). Moreover, the effect of vegetarian diet is difficult to isolate due to the cofounding effect of 
the calorie restriction associated with vegetarian or vegan diets (Ley, Hamdy, Mohan & Hu, 2014). 
Diabetic patients who are physically active have better glycaemic control. In a randomized 
controlled trial involving 251 adult type 2 diabetics in community-based exercise facilities in 
Canada, aerobic exercises or resistance training was found to improve glycaemic control (reduced 
the average HbA1c by an absolute percentage value of 0.51% (aerobic training) and 0.38% 
(resistance training)) after 22 weeks of intervention (Sigal et al, 2007). Sigal et al did not blind 
their participants and this could have a Hawthorne effect. Their findings cannot be generalized to 
diabetics who are less adherent to exercise programs. However, their findings are comparable to 
the results of some systematic reviews in which an absolute reduction of 0.6% was achieved 
through exercise (Boulé et al, 2001; Thomas, Elliott & Naughton, 2006). 
Other studies have withdrawn physical activity in diabetics and found that blood sugar levels of 
these patients increased (Mikus et al, 2012). Most local studies in Nigeria dwell on patients’ 
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adherence to medications ignoring the important role played by behavioural modification. The risk 
associated with unhealthy diet, sedentary lifestyle and alcohol abuse does not stop at causing the 
disease, it perpetuates it and hastens complications. While moderate consumption of alcohol has a 
positive effect on glycaemic control, excessive use worsens glycaemic control (Howard, Arnsten 
& Gourevitch, 2004; Ahmed et al, 2008). Alcohol abuse can precipitate hyperglycaemic crisis in 
type 2 diabetic patients (Kitabchi et al, 2001). Physical inactivity and poor dietary patterns are 
closely associated with overweight and obesity which are risk factors for poor glycaemic control 
amongst diabetic patients (Almutari, Said & Zainuddin, 2013). 
2.3.3 Treatment-Related factors 
The prescribing pattern for diabetic patients is another key determinant of glycaemic control. Cost 
of medicines (Piette, Wagner, Potter & Schillinger, 2004; Enwere, Salako & Falade, 2006), route 
of administration, pill burden and multiple dosing regimens are some prescription-related factors 
that influence glycaemic control (Ary, Toobert, Wilson & Glasgow in Delamater, 2006). Patients 
on simpler regimens (fewer tablets, monotherapies, fewer dosing frequencies) tend to adhere better 
to their medications. Donnan, MacDonald & Morris (2002) reported that diabetic patients on one 
tablet per day had better adherence rates (and better glycaemic control) than patients on multiple 
tablets. They also found a linear trend between the number of tablets and the level of adherence. 
Diabetic patients also adhere better to their medications than behavioural recommendations 
(Delamater, 2006). This makes it more difficult to achieve good level of glycaemic control due to 
the role played by the lifestyle factors in diabetes care. 
Patients’ satisfaction with the quality of health care service provided by the managing hospitals is 
also an important determinant of the possible outcome of the treatment. One way in which this 
quality has been assessed is by eliciting the level of patient satisfaction with the services they 
receive. Alazri & Neal (2003) reported that there is an association between patients’ satisfaction 
and outcome in diabetes-HbA1c. They submitted that steps taken to increase patients’ satisfaction 
(by actualisation of their values and expectations) improve outcome by increasing compliance and 
adherence to treatment regimens. Patients’ satisfaction could therefore be linked to glycaemic 
control amongst diabetic patients. 
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The above review shows that glycaemic control in diabetes is influenced by a wide range of factors 
and failure to adequately control it can lead to serious complications. Understanding the causes of 
poor glycaemic control among diabetic patients is a key step in preventing complications. In 
addition to identifying the reasons why diabetic patients have poor blood glucose control, it is 
envisaged that this study will fill in some gaps that exist in the currently available literature. 
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CHAPTER 3 RESEARCH DESIGN AND METHODOLOGY 
3.1 Aim 
To describe glycaemic control and determine the socio-economic, behavioural and treatment-
related factors that influence glycaemic control among adult diabetic patients attending outpatient 
clinics in tertiary hospitals in Abuja, Nigeria 
3.2 Objectives 
• To determine the level of glycaemic control amongst adult type 2 diabetic patients in Abuja  
• To determine if there is an association between socio-economic factors and glycaemic 
control 
• To determine if there is an association between behavior and lifestyle and glycaemic 
control 
• To determine if the nature of treatment influences glycaemic control in adult type 2 diabetes 
patients 
3.3 Methods 
3.3.1 Study Setting 
The study was done in 2 tertiary hospitals in Abuja, Nigeria. Abuja became the capital of Nigeria 
in 1991 and has a land mass of about 7,315 km2. The population is growing rapidly and the rate of 
development is high. Currently the population stands at about 1.5 million, 60% of whom still reside 
in rural settlements. Abuja is made up of 6 area councils- 3 rural (Abaji, Kuje and Kwali) 2 semi-
urban (Gwagwalada and Bwari) and 1 urban (Abuja Municipal Area Council). The seat of the 
country’s political power is in the municipal council but development is slowly spreading into the 
other councils. The healthcare facilities and health manpower in Abuja are inadequate and are 
inequitably distributed and accessibility is poor especially for rural dwellers. There are 2 tertiary 
hospitals in Abuja viz. the National Hospital (located in the municipal council) and University of 
Abuja Teaching Hospital (located in Gwagwalada). Twenty percent of confirmed diabetic patients 
in Nigeria attend diabetes clinics in the tertiary hospitals. Majority of the patients (about 50%) 
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follow up their diabetes at the secondary-level general or specialist hospitals and private hospitals 
(Fasanmade & Dagogo-Jack, 2015). The remaining 30% of the diagnosed diabetic patients either 
buy antidiabetic drugs from pharmacy outlets and patent medicine dealers or simply ignore their 
ailment.  
It is worth noting that the most comprehensive multidisciplinary diabetes care can only be provided 
in the tertiary hospitals because of the constant availability of the specialists in different fields and 
the required equipment for diabetic care. These third-tier hospitals also serve as a reference 
hospital for the secondary and primary care hospitals and are often overwhelmed by the volume 
of patients they attend to. Most of the Abuja inhabitants (like in the entire Nigeria) has no health 
insurance and so pay out of pocket for all medical expenses. Amongst the insured patients, majority 
are only enjoying a partial insurance scheme. The poverty rate per capita in Nigeria is 33.1% with 
a wide gap between the rural areas (44.9%) and urban areas (15.8%) (World Bank, 2014). Fifty-
eight percent of the Abuja population are literate (National Bureau of Statistics, 2010). 
3.3.2 Study Design 
An analytical cross-sectional study design was utilized because it was more logistically plausible 
than a prospective cohort or a randomized controlled trial (Stone & Campbell, 1984). With the 
cross-sectional design, the prevalence of poor glycaemic control among diabetic patients was 
determined and at the same time, the social-economic attributes of the population were described. 
The nature of the treatment was also explored (oral vs. insulin, number of medications, cost of 
medications). The questionnaires were interviewer-administered. The socio-economic and 
behavioral characteristics of the people with good glycaemic control (HbA1c <7% or average FPG 
<126mg/dl) was then compared with the group with poor glycaemic control (HbA1c >7% or 
average FPG >126mg/dl). Although this design could establish association between poor 
glycaemic control and social factors, it cannot prove causality (Stone & Campbell, 1984). 
3.3.3 Study Population 
The study included type 2 diabetic patients aged between 20 and 79 years attending outpatient 
diabetes or endocrinology clinic with a confirmed diagnosis (by a physician) as evidenced in the 
treatment records. The included patients must have had at least one HbA1c or two FPG tests done 
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within the last 3 months. Only patients who have been on drug treatment or lifestyle modification 
for at least 6 months were included. Pregnant women were excluded because they represent a 
different group of diabetic patients whose problem might be due to the pregnancy and their 
motivation for positive adherence behaviours is different. Patients with debilitating mental illness 
were also excluded due to inability to give informed consent. Patients who have attended the 
diabetes clinic for any reason previously during the survey period and has been interviewed already 
were also excluded to avoid inclusion of a person multiple times. To ensure single response, a note 
was attached to the patient’s case note after the interview. 
3.3.4 Sample Size and Sampling Procedure 
The sample size calculation was reworked when saturation (most patients who were presenting at 
the diabetes clinic have already been interviewed previously) was reached during data collection. 
This was a sign that the sample size was previously overestimated. Therefore, the parameters in 
the calculation below differs from the parameters used in the research proposal. 
The sample size was calculated using Epiinfo Statcalc function. At first the population size was 
calculated using the population figures and IDF prevalence of diabetes (diagnosed and 
undiagnosed) in Nigeria. According to the 2006 National census figures (Nigeria Population 
Commission, 2017) the estimated population of Abuja is 1,406,239. With a diabetes prevalence of 
1.9% (IDF, 2015), the population of diabetics in Abuja was calculated to be 26,719. Amongst this 
population, about 90% are type 2 diabetics (IDF, 2015) and this gives the population of type 2 
diabetic patients in Abuja to be 24,047. Since only 33.3% of diabetic patients are diagnosed or 
confirmed in Nigeria (IDF, 2015), the number of diagnosed cases in Abuja was calculated to be 
8,008. When we narrowed down to the study population (tertiary hospitals) -where only 20% of 
diagnosed cases of diabetes receive care-, we arrived at a population size of 1602. In other words, 
about 1,602 diabetic patients were being managed in the two tertiary hospitals in Abuja. 
Secondly, an expected frequency of 68% was used in the sample size calculation. This represented 
the proportion of diabetic patients in Nigeria with poor glycaemic control (Chinenye et al, 2012). 
Considering the above assumptions, a 95% confidence interval, 5% acceptable margin of error, a 
design effect of 1, and 2 clusters, a raw sample size 278 was calculated using the Statcalc function 
of Epiinfo. In order to compensate for potentially missing or incomplete data, an additional 15% 
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of the raw sample size was added and this yielded a minimum sample size of 320. However, a total 
of 327 diabetic patients were sampled using a consecutive sampling technique on the outpatient 
clinic days at the diabetes or endocrinology clinics of the two study hospitals. 
3.3.5 Data Collection and Processing 
The data was collected between 15th December 2016 and 9th March 2017 at National hospital 
(NHA) and University of Abuja teaching hospital (UATH). Each of the two hospitals had one 
endocrinology clinic day per week (NHA-Tuesdays, UATH-Thursdays). On each of those days 
the clinic runs from around 9.00am to 3.00pm. They care for patients with endocrine abnormalities 
with about 70% of the patients being managed for diabetes. 
Patients’ case notes and semi-structured interviewer-administered questionnaires were the tools 
used in data collection. Data such as medical history (age of onset, duration of disease, family 
history), demography (age, sex, educational level), HbA1c test value and/or latest two FPG test 
results were extracted from the case notes if available. This information was also corroborated by 
the patients. Seven data collectors/interviewers were recruited and trained specifically for this 
study. The other variables being assessed in the study i.e. sociodemographic attributes, treatment 
related factors, healthcare provider associated variables, behaviour and lifestyle and complications, 
were ascertained from the patients through the questionnaire which was in English language. Most 
of the patients understood English language but a few of them who did not understand English 
were interviewed through the help of an interpreter who in all cases were the patient’s relative. 
The patients were interviewed in the morning of their clinic days before or after consulting their 
doctor.  Informed consent was obtained after providing full information to the patient.  A copy of 
the questionnaire, participant information sheet and informed consent have been included in the 
appendix. 
3.3.6 Data Analysis 
The data collected in the questionnaire was coded and entered into Microsoft Excel with the 
columns representing the variables and the rows representing the participants. Data cleaning was 
done in Microsoft Excel by sorting each column/variable to pick out outliers and omitted data. 
Misspelt entries and wrong codes were corrected after double checking against the original 
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questionnaire. The cleaned-up data was then exported to Epi Info software for analyses. The hard 
copies of the questionnaires and consent forms will be stored in a safely secured place and will be 
disposed after 5 years.  
Descriptive analyses were done using the Epi Info based on the objectives of the study. Numerical 
variables were analysed by generating the mean, median, standard deviation, variance and range 
of the values. Frequency tables were generated for the categorical variables. Some of the 
categorical variables were converted to binary/dichotomous variables to allow for the calculation 
of a relative measure for comparison and estimation of strength of association. 
The measures of central tendency and dispersion were calculated for the outcome variables- 
HbA1c and FPG. These variables were converted from numerical to categorical variables in order 
to have two outcome categories of ‘good glycaemic control’ and ‘poor glycaemic control’. Patients 
who had a HbA1c value of 7% or more (or average FPG of 126mg/dl or more when HbA1c test is 
not available) were grouped as having poor glycaemic control. This new grouping was used to 
calculate the prevalence of poor (and good) glycaemic control in our study population. 
In each of the exposure variables considered, the level of glycaemic control was compared across 
the different categories using cross-tabulations in Epi Info. 
3.3.7 Validity, Reliability and Generalizability 
The sample calculation was based on 95% confidence level and 5% margin of error in order to 
obtain a sample large enough to limit the probability of chance influencing the results. All diabetic 
patients attending the clinic within the data collection period were approached. To ensure 
reliability, we recruited experienced data collectors who were further retrained for this study in 
particular. The same set of data collectors were used in the two study hospitals and efforts were 
made to question the respondents in similar conditions to minimize measurement error. We also 
utilized standard tools of measurement especially by adopting many questions in the already 
validated diabetes self-care questionnaire by Toobert, Hampson & Glasgow (2000). Clear 
operational definitions of the variables were used and the data collectors were conversant with 
these definitions. The anthropometric measurements (Height, body weight and waist 
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circumference) where measured by the data collectors during the interview as the data in the case 
notes were sometimes outmoded.  
The results of this study can only apply to the study population but it is anticipated that the findings 
and recommendations will be relevant to a wider population of diabetes patients and diabetes care 
providers in Nigeria. 
3.4 Limitations of the Study 
Being a cross-sectional study, it is not possible to make causal inferences from the study due to 
lack of temporality between the outcome and exposure. The measured outcome represents a 
snapshot of the population characteristics and this might differ if a different time-frame is chosen 
(seasonal bias). For example, the number of patients coming to the diabetes clinic reduced 
significantly during the Christmas period (23rd December 2016 to 8th January 2017) and very few 
patients were interviewed during this period and these were mostly Muslim patients and are mainly 
from the Northern part of the Nigeria. This could lead to bias. Secondly, patients who are surveyed 
immediately after the festive period could have gained more weight than usual because of the 
increased dietary intake associated with the Christmas season. If these patients have no HbA1c test 
result, their FBG could also be higher than usual and this could bias the level of glycaemic control 
in the study population. 
Due to unknown confounders, interpreting the result from different categories of an exposure 
variable may be misleading. It is possible that the respondents may not have provided the accurate 
information especially for socially undesired behaviours such as smoking, alcohol, unhealthy diet 
and drug dose omission. The quality of the data that was extracted from patient’s case notes cannot 
be authenticated. However, the anthropometry was measured for all patients as the values in the 
case notes were mostly out of date.  A lot of the patients did not provide information regarding 
their income because of the sensitivity of the issue in the study setting and also the high number 
of persons with informal and irregular income. The missing income information was more 
prevalent in the unemployed group which led to the underrepresentation of the unemployed 
individuals in the income analyses.  
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Being teaching hospitals, our study clinics were also research institutions. The effect of this was 
that convincing patients to enroll into the study was more difficult as most of the patients have 
been involved in several researches during the course of their follow ups. Some patients declined 
from the study due to this reason. The study is therefore prone to a non-response bias as the patients 
who declined could differ in some ways with the study participants. It is possible that patients who 
have been on follow ups for a longer time would have partaken in more surveys and are more 
likely to refuse to be interviewed. These group of patients could have more complications or could 
have better lifestyle. This study is not able to analyse this effect. 
The use of two different criteria for glycaemic control (HbA1c and FPG) is a significant limitation 
in the study. The lack of HbA1c test for all patients in our study setting makes a uniform criterion 
unachievable. However, the proportion of patients who have a HbA1c test (74%) is higher than 
reported in other studies in Nigeria. The FPG is not a reliable index to estimate glycaemic control 
because it fluctuates with exercise, food or drug intake. The 26% of the study population whose 
level of glycaemic control was determined using the FPG could have HbA1c level of any value. 
The result f the study therefore may not be an accurate representation of the glycaemic control of 
the study population. 
3.5 Ethical Considerations 
The proposal was approved by the Ethics Committee of the University of the Western Cape 
(reference number- BM/17/1/16) and permission was granted by the Ethics committee of the 
University of Abuja Teaching Hospital (reference number- FCT/UATH/HREC/PR/569) and 
National Hospital Abuja (reference number- NHA/EC/091/2016). Copies of the 3 letters of ethical 
approval has been attached as appendices (Appendix 4-6).  
All respondents participated voluntarily after a detailed explanation with the aid of the participants’ 
information sheet (a copy of which was also made available to all respondents). The benefits, risks 
and voluntary nature of the study were clearly communicated to them and the assurance of the 
confidentiality of their data was given. A written and signed informed consent was obtained. As 
the study did not involve any invasive procedure, the adverse physical, psychological or emotional 
harm to the respondents was low. However, the indirect harm that may have arisen during the 
course of the study was addressed accordingly. There were no consequences whatsoever for 
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patients who refused to participate in the study. Participant names were not written on the 
questionnaires and the results of the study will only be made available to the public as averaged 
figures. 
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CHAPTER 4 RESULTS 
4.1 Introduction 
This chapter will present the findings from the study including the characteristics of the study 
population and their glycaemic control. The association between the level of glycaemic control of 
the patients and their socio-demographic characteristics and nature of treatment were determined 
by crosstabulations and the Pearson's χ2 p value used to determine significance (Table 4.2, 4.3 and 
4.4). 
The association between patients’ behaviour and glycaemic control was determined using both 
crosstabulations and ANOVA test. The ANOVA test was done for certain behavioural variables 
which were lifted from the Diabetes Self-Care Activities (SDSCA) questionnaire. The responses 
were scored and the mean number of days that the behaviour was performed calculated and then 
compared in the two outcome groups (good vs. poor blood glucose control) (Table 4.5). Although 
some authors have used ANOVA to analyze the SDSCA questionnaire (Toobert, Hampson & 
Glasgow, 2000; Lin et al 2016) due to its robustness and ability to manage some violations in 
normality in the absence of outliers, the non-parametric distribution of these set of variables 
necessitated the use of the Kruskal-Wallis test statistic which is a one-way ANOVA for non-
parametric data. In order to understand the practices of patients, these behavioural/lifestyle 
variables were also analysed as categorical data (Table 4.3). 
Prior to performing the analyses, missing information analyses was done to determine if any biases 
may be present. The only variable where the participants with missing information differed 
significantly from those who provided information, was income. The relative distribution of age, 
gender, residence, education, duration of treatment, nature of treatment, employment and blood 
glucose control in the ‘missing income’ and ‘given income’ group were compared and only 
employment status varied significantly amongst those that provided income information and those 
who did not (Table 4.1). About 13.5% and 13.6% respectively of the ‘employed’ and ‘retired’ 
population had missing income data whilst 30.2% of the ‘unemployed’ group had missing income 
data. Income data is therefore skewed towards those that earn some form of income. 
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4.2 Socio-demographic characteristics  
Three hundred and twenty-seven type 2 diabetic outpatients attending follow-up clinics in two 
tertiary hospitals in Abuja, Nigeria-National hospital (n=144) and University of Abuja Teaching 
Hospital (n=183)- were surveyed in an effort to determine the relationship between their level of 
glycaemic control and their sociodemographic background, behaviour and treatment modality.  
4.2.1 Age and Gender 
The respondents, aged between 25 and 79 had an average age of 54 ± 11 years and their mean age 
at first diagnosis was 45 ± 11 years. The male to female ratio was 2:3 with about 88% of the 
respondents being married.  
4.2.2 Income, Education, Employment and Residence 
Regarding their monthly family income, 32%, 57% and 11% of the respondents were low (< 
50,000 Naira), middle (50,000 to 200,000 Naira), and high income (>200,000 Naira) earners 
respectively (Table 4.2). Eight percent of the respondents had no education at all whereas 11%, 
25% and 56% had completed primary, secondary and tertiary education respectively. In terms of 
employment, 16%, 20% and 64% of the surveyed patients were unemployed, retired and employed 
respectively during the period of the data collection. Seventy-four percent of the respondents were 
urban dwellers while 26% resided in rural settlements (Table 4.2). 
4.2.3 Family History, Comorbidities and Medications 
Fifty two percent of the participants had a positive family history of diabetes. Sixty-two percent 
of respondents were being treated with oral medications only, 8% on insulin-only treatment while 
28% were on both insulin and oral medications (Table 4.4). The average duration of diabetes 
treatment for the study population was 9.2 ± 6.8 years. Seventy-five percent of the patients had 
other comorbidities like hypertension (64%), dyslipidemia (5%), cardiac problems (4%), 
osteoarthritis (5%) and other diseases. The average pill load for the patients on oral medication 
was 4.8 tablets per day. Two thirds of the respondents were taking 5 or less tablets per day and the 
rest is taking >5 tablets per day. A further subanalysis revealed that most of the patients (55%) 
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were on more than 4 ± 2.4 tablets per day, while 10% and 35% of them were on ≤ 2 tablets and 3-
4 tablets respectively per day. 
4.2.4 Health Insurance coverage and Finance 
Seventy percent of the patients had no health insurance coverage and therefore had to pay for their 
treatment either out-of-pocket or sponsored by their family. Insurance coverage for the rest of the 
patients were mainly partial (24%) with just 6% of the respondents having full insurance coverage. 
Forgetfulness (33%) and financial constraints (14%) were the most implicated reason for poor 
adherence to diabetes medications. 
4.2.5 Anthropometry and Physical Activity 
322 of the respondents had a complete set of anthropometric data available. The other 5 
respondents were physically unable to tolerate the measurement procedure. The mean BMI for the 
study population was 28.9 kg/m2 ± 6.4 kg/m2 (male average= 28.9 kg/m2; female average=29.0 
kg/m2) while the mean waist circumference was 97.6cm ± 15.0cm (male average=98.0cm; female 
average=97.3cm). About 34% of the study population were obese (i.e. BMI ≥30 kg/m2) and 65% 
were physically inactive (Table 4.3).  
4.2.6 Self-monitoring of Blood Glucose, Patients’ Satisfaction, Counselling by 
Healthcare Providers and Adherence to Healthy Eating Plan 
Thirty-four percent of the respondents had done daily self-monitoring of blood glucose in the past 
one week. Majority of the patients (91%) were satisfied with the level of care provided by the 
managing hospitals (Table 4.4). Over 90% of the respondents reported having been properly 
counselled about diet, exercise and blood glucose measurement by the diabetes management 
teams. However, only 49% of the patients sampled adhered strictly (followed the plan for 6-7 
days/week) to a healthful eating plan and 33% consumed fruits and vegetables regularly 
(consumed at least 5 portions of fruits and vegetables in 6-7 days/week) (Table 4.3). 
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4.2.7 Complications 
In terms of complications, 37%, 28%, 9%, 7%, 7% and 2% of the respondents have suffered from 
or are suffering from diabetic retinopathy, neuropathy, nephropathy, foot ulcer, stroke and 
myocardial infarction respectively. 
4.3  Glycaemic Control 
Glycated haemoglobin (HbA1c) and fasting plasma glucose were the two parameters used to assess 
the level of glycaemic control of the patients. HbA1c, being the internationally recommended gold 
standard for monitoring glycaemic control was given a priority in assessing how well the patients’ 
blood glucose was controlled. Although the HbA1c test is not usually accessible to most diabetic 
patients in LMICs, about 74% of our study sample (241) had a HbA1c test result not older than 6 
months. For this group of patients, a HbA1c of less than 7% was regarded as good glycaemic 
control based on the American Diabetes Association diabetes protocol. The mean HbA1c of the 
respondents was 7.6% ± 2.4% and the value ranged from 3% to 15.3%. Ten of the participants 
(3%) had a HbA1c value of less than 4%, which is subnormal considering that healthy persons 
without diabetes have a HbA1c concentration of 4-6% (Chu, Wang, Sun, Lee & Lam, 2007). 
Possible causes of this will be discussed in Chapter 5. 
For the rest of the participants (n=86) who had no recent HbA1c test result, the average of their 
latest 2 fasting plasma glucose (FPG) measurements was used to ascertain their level of glycaemic 
control. Patients with average FPG of less than 126 mg/dl were categorized as having good 
glycaemic control whereas those with greater than or equal to 126 mg/dl average FPG were classed 
as poor glycaemic control. The average FPG of our study population was 142 mg/dl ± 53.8mg/dl 
ranging from 63 mg/dl to 423 mg/dl. 
With the above criteria, a new outcome variable-Glycaemic control- was defined in which two 
groups of outcomes emerged- good glycaemic control (HbA1c <7% or average FPG less than 126 
mg/dl if HbA1c is not available) and poor glycaemic control (HbA1c ≥7% or average FPG ≥126 
mg/dl if HbA1c is not available). The final analysis revealed that 53% of the patients sampled 
(n=173) had poor glycaemic control and 47% (n=154) had good glycaemic control. 
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4.4 Socio-demographic Factors and Glycaemic Control 
Some of the socio-demographic factors that has been explored in this study include: age, gender, 
marital status, residence, family history of diabetes, income, education, employment and available 
means of healthcare financing.  
4.4.1 Age 
The values presented in Table 4.2 shows that the majority of our study population fall within the 
age group 50-59 (33%) and 40-49 (28%). Fifty percent of the patients in the ‘< 40’ and’40-49’ age 
group had poor glycaemic control while 56% of the patients in the ’50-59’ age group had poor 
glycaemic control. Fifty-two percent of the patients in the ‘60+’ category had poor glycaemic 
control (Figure 4.1). This observed difference is however not statistically significant (χ2=0.95, 
df=3, p=0.813). A further subcategorization of the age revealed that the worst glycaemic control 
was seen in extremes of ages (20-29 age group-67% of whom had poor control and 70-79 age 
group- 70% of whom had poor control) (df=5, p=0.178). It is important to note that the small 
frequencies in the 20-29 age group (n=6) might have influenced this statistic. 
 
Figure 4.1: Proportionate distribution of poor glycaemic control by age group of patients attending the two 
tertiary hospitals (NHA and UATH) in Abuja, Nigeria 
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4.4.2 Gender 
There was no statistically significant difference between female diabetic patients and male diabetic 
patients in terms of glycaemic control (χ2=0.069, p=0.793) (52% of the females had poor control 
while 54% of the males had poor control) (Table 4.2).  
4.4.3 Marital Status 
Forty-six percent of the married patients had good glycaemic control while half of the patients who 
were single or widowed had good blood glucose control. The 2 patients who were separated from 
their spouses had good glycaemic control. These differences were not statistically significant 
((χ2=3.2, df=3, p=0.357).  
4.4.4 Residence 
There was no statistically significant difference in the rate of poor glycaemic control between rural 
(55%) and urban (52%) inhabitants (χ2=0.2, p=0.609).  
4.4.5 Family History of Diabetes 
Patients who had a previous family history of diabetes had better glycaemic control (50% had good 
control) than those without a family history (44% had good control). This difference was not 
statistically significant ((χ2=1.5, p=0.226) (Table 4.2). 
4.4.6 Income 
The differences observed across the different income groups were not statistically significant 
(χ2=2.4, p=0.298). However, the high-income group had a higher rate of poor glycaemic control 
(65%) compared to middle-income (53%) and low-income (48%) earners (Figure 4.2). It should, 
however be noted that 17% of the study population did not report income information and that 
missing income information was more prevalent in the unemployed group which leads to the 
underrepresentation of unemployed individuals in the analyses. 
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Figure 4.2: Proportionate distribution of poor glycaemic control by income of patients attending the two 
tertiary hospitals (NHA and UATH) in Abuja, Nigeria. 
4.4.7 Education 
No statistically significant association was seen between glycaemic control rate and level of 
education but the trend shows worsening glycaemic control with increasing level of education 
(χ2=1.4, df=3, p= 0.717) (Table 4.2, Figure 4.3). Patients who had no education had the lowest rate 
of poor glycaemic control (44%) while the patients who had tertiary education had the highest rate 
of poor glycaemic control (55%). Diabetic patients who had completed primary education and 
secondary education had a poor glycaemic control rate of 49% and 53% respectively (Figure 4.3). 
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Figure 4.3: Proportionate distribution of poor glycaemic control by level of education of diabetic patients 
attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria. 
4.4.8 Employment 
In terms of employment, the differences in the rate of poor glycaemic control in the different 
categories (employed-54%, retired-53% and unemployed-49%) was not statistically significant 
(χ2=0.4, df=2, p=0.806) (Table 4.2, Figure 4.4).  
 
Figure 4.4: Proportionate distribution of poor glycaemic control by employment status of diabetic patients 
attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria. 
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4.5 Behavioural and Lifestyle-related Factors and Glycaemic Control 
In order to determine a link between the level of glycaemic control and diabetic patients’ behaviour 
and lifestyle, certain behaviours of diabetic patients were analyzed as categorical data and 
statistical significance determined using Pearson’s χ2 statistic. Categorically analyzing these 
variables gives a better insight into the distribution of practices of patients. The variables 
considered include adherence to medication, level of physical activity, self-monitoring of blood 
glucose, adherence to healthful eating plan, patients’ consumption of fruits and vegetables and 
body mass index (as an outcome of lifestyle) (Table 4.3).  
Since a negligible number of the patients were current smokers or heavy drinkers, these behaviours 
were not included in the analysis. Only one patient admitted to being a current smoker. Nine of 
the respondents (2.8%) have taken alcohol within the last week while 11 of them (3.4%) have had 
an alcoholic drink within the last month. Out of the 9 persons who have taken alcohol within the 
last week, five of them admitted to have taken alcohol only once within the last 7 days while 3 of 
them have taken alcohol on 2 different days in the last week. One patient had taken alcohol on 3 
different days within the last week. Eighty-nine percent of the study population took some 
alcoholic beverage more than two years prior to the survey or have never taken an alcoholic 
beverage. 
In addition to the analysis above, an ANOVA test was done for the behavioural variables. A 
continuous scale ranging from 0-7 was used to numerically score the items based on the number 
of days of the week that the behaviour was performed. The mean of each item score was calculated 
and compared across the two groups of outcomes (good vs poor glycaemic control) (Table 4.5). 
These items were lifted from the Diabetes Self-Care Activities (SDSCA) questionnaire. The 
ANOVA test is a preferred method of analysis for many authors (Toobert, Hampson & Glasgow, 
2000; Lin et al, 2016). Toobert et al further analysed the behaviours in groups- physical activity, 
self-monitoring of blood glucose, foot care, adherence to recommended medication and diet. With 
the exception of diet (due to low inter item correlation), all the other behaviours in this study were 
analysed in groups after the mean number of days were calculated for all the items in a particular 
‘behaviour’ group. The average score of items 24 and 25 in the questionnaire (Appendix 3) was 
used for physical activity. The individual average scores of each of the items 32, 33, 34, 35 (after 
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reversing the item) and 37 were used to analyse the ‘diet’ activity and the means compared across 
the two glycaemic control outcomes. In terms of adherence to recommended medication, item 38 
mean score was used. The average scores of items 39 and 40 were used to analyse the ‘self-
monitoring of blood glucose’ behaviour. The mean scores of items 41-45 (with reversal of 42) 
were used to analyse the footcare activities of the patients across the glycaemic control groups. 
Table 4.5 summarizes the statistic. Because of the non-parametric nature of these score variables, 
the Kruskal-Wallis test was used to determine the significance of the differences in means. 
 The proportion of patients who never missed their medications with good glycaemic control was 
52% while that of those in the ‘seldom’, ‘sometimes’ and ‘often’ group were 38%, 39% and 52% 
respectively. This was not statistically significant (χ2 p= 0.199) (Table 4.3). There was also no 
statistically significant difference in the mean number of days that patients ingested their 
recommended medications within the last one week in the two glycaemic control groups (good 
BG mean=6.32 days, poor BG mean= 6.35 days, Kruskal-Wallis test p= 0.955) (Table 4.5). 
Generally, the respondents were adherent to their medications on most days. In terms of footcare 
behaviours, no statistically significant difference was seen in the two outcome groups (3.31days 
(good glycaemic control) vs 3.12 days (poor glycaemic control) (Kruskal-Wallis test p=0.247) 
(Table 4.5). 
There was no statistically significant difference observed in the poor glycaemic control rate 
between physically active (51%) and physically inactive (54%) diabetic patients (χ2=0.289, 
p=0.591, OR=1.133 (95% CI 0.717-1.789)) (Table 4.3, Figure 4.5). The ANOVA analysis of the 
physical activity level of the patients (Table 4.5) shows that patients who had good glycaemic 
control had higher mean number of days in which they were physically active compared to those 
with poor glycaemic control (2.99 days vs. 2.52 days). This finding was also not statistically 
significant (Kruskal Wallis test p= 0.117). 
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Figure 4.5: Proportionate distribution of poor glycaemic control by physical activity level of diabetic 
patients attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria. 
In terms of BMI, there was no statistically significant difference in the rate of poor glycaemic 
control between patients who were normal or overweight and those who were obese (53% and 
55% respectively; χ2 =0.161, p=0.688, OR=0.910 (95% CI 0.572-1.445) (Figure 4.6). Obese 
diabetic patients are 0.91 times less likely to have good control of their blood glucose in 
comparison with normal/overweight patients. 
 
Figure 4.6: Proportionate distribution of poor glycaemic control by BMI of diabetic patients attending the 
two tertiary hospitals (NHA and UATH) in Abuja, Nigeria. 
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Table 4.3 also shows that patients who self-monitored their blood glucose infrequently had a higher 
rate of good glycaemic control (51%) compared to the patients that monitored more frequently 
(41%). This association was not statistically significant ((χ2 p=0.076, OR=1.490 (95% CI 0.958-
2.325)). Similar trend was also found when the average number of days was compared across the 
two outcome groups. Patients with poorly controlled blood glucose had a higher mean score of 
3.68 days while patients with good blood glucose control had a lower mean score of 3.21 days. 
This finding was also not statistically significant (Kruskal-Wallis test p=0.169) (Table 4.5). 
Adherence to a healthful eating plan was found to be a significant factor in blood glucose control 
as patients in the ‘non-adherence’ group (patients who follow a healthful eating plan for 0-1 
day/week) were found to have the worst level of glycaemic control. Sixty-four percent (64%) of 
the patients in this group had a poor glycaemic control. Not much difference existed between the 
other three categories- ‘good adherence’ (47% had poor glycaemic control), ‘moderate adherence’ 
(47% with poor control) and ‘poor adherence’ (46% with poor control) group. (Table 4.3, Figure 
4.7a). This finding was statistically significant. (χ2 =8.58, p=0.036). When this variable was 
considered as a numeric variable (by calculating the mean number of days in the last week that 
patient followed a healthful eating plan), the difference in the mean of the ‘good’ and ‘poor’ 
glycaemic control groups was also found to be statistically significant. On the average, patients 
with good glycaemic control followed a healthful eating plan for 4.38 days within the last week. 
On the other hand, patients with poor control followed a healthful eating plan only for 3.47 days 
in the last week (Kruskal-Wallis test p=0.017) (Figure 4.7b). Other dietary behaviours (fruits and 
vegetables consumption, avoidance of high fat foods like red meat and full cream dairy products) 
were also found to be significant in determining glycaemic control. The patients with good 
glycaemic control generally adopted healthier diet-related behaviours (Table 4.5). The only diet-
related behaviour that was not significantly different in the two outcome groups was frequency of 
evenly spacing carbohydrates (Kruskal-Wallis test p=0.357). It should be noted however, that 
patients with good glycaemic control, on the average, spaced their carbohydrate meals more 
frequently that those with poor glycaemic control (4.64 days vs. 4.31 days). 
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Figure 4.7a: Proportionate distribution of poor glycaemic control by adherence to healthful eating plan by 
diabetic patients attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria. 
 
Figure 4.7b: Box plot comparing the mean number of days diabetic patients attending the two tertiary 
hospitals Abuja followed a healthful eating plan stratified by Glycaemic control. (Y-axis: BGContro- blood 
glucose control; X-axis: number of days patients followed a healthful eating plan) 
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those who seldom (No consumption or only 1 day per week) ate adequate amounts of fruits and 
vegetables had the worst glycaemic control (36% had good control and 64% had poor control) 
(Table 4.3, Figure 4.8a). This result was however not statistically significant (χ2=6.004, df=3 
p=0.111). When the ‘fruits and vegetables’ variable was analyzed using the ANOVA test, the 
difference in the two outcome groups was found to be significant (Kruskal-Wallis test p=0.040). 
The ‘good blood glucose control’ group consumed adequate amount of fruits and vegetables on 
average 4.4 days in the last week while the ‘poor blood glucose control’ group consumed adequate 
fruits and vegetables, on average for 3.80 days in the last week (Table 4.5, Figure 4.8b) 
 
Figure 4.8a: Proportionate distribution of poor glycaemic control by consumption of fruits and vegetables 
by diabetic patients attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria 
47%
53% 52%
67%
0%
10%
20%
30%
40%
50%
60%
70%
80%
Regular (6-7
days/week)
Often (4-5
days/week)
Sometimes (2-3
days/week)
Seldom (0-1
day/week)
%
 W
it
h
 p
o
o
r 
g
ly
ca
em
ic
 c
o
n
tr
o
l
Consumption of fruits and vegetables
(χ2 = 6.004, p = 0.111)
http://etd.uwc.ac.za
33 
 
  
Figure 4.8b: Box and whisker plot comparing the mean number of days diabetic patients attending the two 
tertiary hospitals Abuja consumed at least 5 portions/servings of fruits and vegetables stratified by 
Glycaemic control. (BGContro- blood glucose control) 
4.6 Nature of Diabetes Treatment and Glycaemic Control 
The type of medication, pill burden and healthcare providers’ influence are some treatment related 
variables that were considered in this study. As seen in table 4.4, glycaemic control rate varied 
according to the nature of diabetes treatment. Fifty-one percent of patients on only oral medications 
had good glycaemic control while 52% of patients on insulin-only treatment had good glycaemic 
control. Patients on combined insulin and oral treatment had a much lower rate of glycaemic 
control (35% had good control). Out of the 5 patients who were on non-pharmacological 
treatment/lifestyle modification, 3 had a well-controlled blood glucose level. Two patients were 
not on any specific treatment and both had a good glycaemic control. These differences were found 
to be statistically significant (χ2=9.814, df=4, p=0.044) (Figure 4.9). 
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Figure 4.9: Proportionate distribution of poor glycaemic control by ‘type of treatment’ prescribed for 
diabetic patients attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria 
The study shows that pill burden and glycaemic control had no statistically significant association 
but the tendency shows that patients with higher pill burden (>5 tablets/day) had a better level of 
glycaemic control (52%) compared to those with lower pill burden (45%) (Table 4.4, Figure 4.10) 
(χ2=1.480, p=0.224, OR=0.752 (95% CI 0.474-1.193)). The low pill burden group were 0.752 
times less likely to have a good level of glycaemic control. 
 
Figure 4.10: Proportionate distribution of poor glycaemic control by pill burden of diabetic patients 
attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria 
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Ninety-one percent (91%) of the study population were generally satisfied with the quality of care 
provided by their management team and 49% of them had good glycaemic control. In the case of 
the ‘dissatisfied’ group, 30% of them had good glycaemic control. This difference was found to 
be statistically significant ((χ2=3.862, p=0.049, OR=0.450 (95% CI 0.190-1.003) (Figure 4.11, 
Table 4.4). 
 
Figure 4.11: Proportionate distribution of poor glycaemic control by level of satisfaction of diabetic patients 
attending the two tertiary hospitals (NHA and UATH) in Abuja, Nigeria 
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Table 4.1 Missing income analysis by Employment 
 
 
 
 
 
 
 
 
 
 
  
χ2 p = 0.011, df=2 
 incomemissing   
EMPLOYMENT 0 (missing) 1 (given) Total 
0 (Unemployed) 16 (30.19%) 37 (69.81%) 53 (16.26%) 
1 (Employed) 28 (13.53%) 179 (86.47) 207 (63.50%) 
2 (Retired) 9 (13.64%) 57 (86.36%) 66 (20.24%) 
TOTAL 53 (16.26%) 273 (83.74%) 326 (100%) 
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Table 4.2 Socio-demographic characteristics of diabetic patients by glycaemic control 
Indicator Number (n) 
Total (%) 
Blood Glucose 
Control 
Chi-
square p-
value 
Odds 
risk 
(OR) 
95% CI of OR 
Good Poor Lower Upper 
Age 
< 40 24 (7%) 12(50%) 4 (50%) 0.813    
40-49 90 (28%) 45 (50%) 45(50%)     
50-59 108 (33%) 47 (44%) 61 (56%)     
60+ 105 (32%) 50 (48%) 55 (52%)     
Gender 
Male 132 (40%) 61 (46%) 71 (54%) 0.793 0.943 0.604 1.469 
Female 195 (60%) 94 (48%) 101(52%)     
Marital Status (4 categories) 
Single 6 (2%) 2 (33%) 4 (67%) 0.357    
Married 289 (88%) 134(46%) 155(54%)     
Widowed 30 (9%) 16 (53%) 14 (47%)     
Separated 2 (1%) 2 (100%) 0     
Marital status (2 categories) 
Married 289 (88%) 134(46%) 155(54%) 0.467 0.779 0.391 1.543 
Not married 38 (12%) 20 (53%) 18 (47%)     
Residence 
Rural 85 (26%) 38 (45%) 47 (55%) 0.609 0.879 0.532 1.445 
Urban 242 (74%) 116(48%) 126(52%)     
Family History 
No Family 
History 
156 (48%) 68 (44%) 88 (56%) 0.226 0.764 0.493 1.183 
Positive Family 
History 
171 (52%) 86 (50%) 85 (50%)     
Income 
High income 31 (11%) 11 (35%) 20 (65%) 0.298    
Low income 87 (32%) 45 (52%) 42 (48%)     
Middle income 155 (57%) 73 (47%) 82 (53%)     
Education 
No education 27 (8%) 15 (56%) 12 (44%) 0.717    
Primary 37 (11%) 19 (51%) 18 (49%)     
Secondary 81 (25%) 38 (47%) 43 (53%)     
Tertiary 182 (56%) 82 (45%) 100(55%)     
Employment 
Employed 207 (64%) 95 (46%) 112(54%) 0.806    
Retired 66 (20%) 31 (47%) 35 (53%)     
Unemployed 53 (16%) 27 (51%) 26 (49%)     
Means of financing diabetes treatment 
Full insurance 21 (6%) 9 (43%) 12 (57%) 0.359    
Partial 
insurance 
77 (24%) 37 (48%) 40 (52%)     
Self-payment 150 (46%) 77 (51%) 73 (49%)     
Family 
sponsored 
79 (24%) 31 (39%) 48 (61%)     
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Table 4.3 Behaviour and lifestyle of diabetic patients by glycaemic control 
Indicator Number 
(n) 
Blood glucose 
control 
Chi-
square p-
value 
Odds 
Risk 
(OR) 
95% CI of OR 
Good Poor Lower Upper 
Adherence to medication (How often the patient forgets to take their medication) 
Never 186(57%) 97(52%) 89(48%) 0.199    
Seldom (once/month) 56 (17%) 21(38%) 35(62%)     
Sometimes 
(once/week) 
59 (18%) 23(39%) 36(61%)     
Often (>once/week) 23 (7%) 12(52%) 11(48%)     
Exercise/Physical activity 
Physically active 114 (35%) 56(49%) 58(51%) 0.591 1.133 0.717 1.789 
Physically inactive 213 (65%) 98(46%) 115(54%)     
Body Mass Index 
Obese (BMI ≥30 
kg/m2) 
111 (34%) 50(45%) 61 (55%) 0.689 0.910 0.572 1.445 
Normal/Overweight 
(BMI <30 kg/m2) 
211 (66%) 100(47%) 111(53%)     
Self-monitoring of Blood glucose 
Infrequent (0-3 
days/week) 
187 (57%) 96 (51%) 91 (49%) 0.0762 1.490 0.958 2.325 
Frequent (4-7 
days/week) 
140 (43%) 58 (41%) 82 (59%)     
Adherence to a healthful eating plan 
Good adherence (6-7 
days/weeks) 
159 (49%) 84 (53%) 75 (47%) 0.036    
Moderate adherence (4-
5 days/week) 
17 (5%) 9 (53%) 8 (47%)     
Poor adherence (2-3 
days/week) 
35 (11%) 19 (54%) 16 (46%)     
Non-adherence (0-1 
day/week) 
116 (35%) 42 (36%) 74 (64%)     
Frequency of daily consumption of at least 5 portions/servings of fruits and vegetables 
Regular (6-7 
days/week) 
109 (33%) 58 (53%) 51 (47%) 0.111    
Often (4-5 days/week) 64 (20%) 30 (47%) 34 (53%)     
Sometimes (2-3 
days/week) 
102 (31%) 49 (48%) 53 (52%)     
Seldom (0-1 day/week) 52 (16%) 17 (33%) 35 (67%)     
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Table 4.4 Nature of diabetes treatment by glycaemic control 
Indicator Number 
(n) 
Blood glucose 
control 
Chi-
square 
p-value 
Odds 
Risk 
(OR) 
95% CI of OR 
Good Poor Lower Upper 
Type of treatment 
No specific treatment 2 (0.6%) 2(100%) 0 0.044    
Non-
pharmacological/lifestyle 
modification 
5 (1.5%) 3 (60%) 2 (40%)     
Oral medication only 203(62.1%) 104(51%) 99(49%)     
Insulin injections only 25 (7.7%) 13 (52%) 12(48%)     
Combination Insulin and 
oral medications 
92 (28.1%) 32 (35%) 60(65%)     
Pill burden (Number of tablets per day) 
≤5tabs/day 217 (66%) 97 (45%) 120(55%) 0.224 0.752 0.474 1.193 
>5tabs/day 110 (34%) 57 (52%) 53 (48%)     
Level of Satisfaction with Healthcare provider 
Dissatisfied 30 (9%) 9 (30%) 21 (70%) 0.049 0.450 0.190 1.003 
Satisfied 297 (91%) 145(49%) 152(51%)     
 
Table 4.5 Summary of Diabetes Self-Care Activities (SDSCA) by Glycaemic control in type 2 
diabetes patients attending outpatient diabetes clinic in tertiary hospitals in Abuja, Nigeria 
Activities (Mean number of days 
patient engaged in the 
behaviour)  
Good blood 
glucose 
control 
Poor blood 
glucose 
control 
ANOVA p-
value 
Kruskal-Wallis 
test P-value 
Physical activity  2.99 2.52 0.996 0.117 
Adherence to recommended 
medications 
6.32 6.35 0.873 0.955 
Self-monitoring of blood glucose 3.21 3.68 0.128 0.169 
Footcare 3.31 3.12 0.306 0.247 
Diet 
Following a healthful eating plan 
in the past week 
4.38 3.47 0.010 0.017 
Following a healthful eating plan 
in the past month (average per 
week) 
4.32 3.49 0.017 0.017 
Adequate fruits and vegetables 
consumption 
4.40 3.80 0.025 0.040 
Avoidance of High fatty foods 
such as red meat and full cream 
dairy foods 
5.39 4.97 0.079 0.042 
Even carbohydrate spacing 4.64 4.31 0.263 0.357 
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CHAPTER 5: DISCUSSIONS 
5.1 Socio-demographic Characteristics 
About 60% of the respondents were females. This is similar to the figures (60.6%) reported by 
Chinenye et al (2012) in a multicenter study across 7 tertiary hospitals in Nigeria. This, however 
differs from the 1:1 female to male ratio reported in other studies outside tertiary centers in Nigeria. 
The female preponderance could be related to sex-related lifestyle differences amongst the two 
genders. For example, women in many sub-Saharan African countries are likely to be more obese 
or overweight than their male counterparts because of the cultural acceptability of 
overweight/obesity amongst women in these societies (BeLue et al, 2009).  This could also be due 
to the higher life expectancy of the females in Nigeria compared to the males (National Bureau of 
Statistics (NBS), 2015). Additionally, the healthcare finance model in Nigeria makes it more likely 
that female patients are supported by their relations and loved ones than their male counterparts 
(Chinenye et al, 2012). Furthermore, in the study setting, men are often the bread winners of the 
house and are more likely to ignore or omit clinic visits as this would usually have some economic 
implications to the family. 
The mean age of the study population was 54 ± 11.3 years. Chinenye et al (2012) reported a mean 
age of 57.1 ± 12.3 years. In another study, Adisa et al (2011) reported that the average age of 
diabetic patients in a tertiary hospital in Ibadan, southwestern Nigeria was 61 years. The mean age 
of diabetic patients is generally lower in developing countries compared to developed countries 
where most diabetics are above 64 years (Wild, Roglic, Green, Sicree & King, 2004). The older 
age of diabetics in developed countries could be as a result of longer survival or later onset due to 
better and well financed health system. The lower life expectancy of Nigerian diabetics also means 
that most do not advance to older ages as they develop complications earlier and are at higher risk 
of early mortality (Chinenye et al, 2012). 
In terms of age distribution, majority (60%) of the patients sampled in this study were between 40 
and 59 years. This is the age group with the highest prevalence of type 2 diabetes as corroborated 
by other studies: Adebisi et al (2009) reported that 68% of their diabetes patients attending the 
outpatient diabetes clinic in a teaching hospital in Ilorin, Nigeria were within this age group while 
Adisa et al (2011) had 42% of their respondents within this age group. The International Diabetes 
Federation reported that 50% of all adults with diabetes are between the ages of 40 and 59 (IDF, 
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2013). In a rural South African population, Motala et al (2008) reported a peak prevalence between 
the ages 55-64 years. These findings all support the fact that older age is a key risk factor in onset 
of type 2 diabetes (IDF, 2015). Although, many cases of diabetes are beginning to set in at earlier 
ages, majority are still diagnosed after 40 years. In our study, the mean age at diagnosis was 45 
years. Chinenye et al (2012) reported a mean age at onset of diabetes of 48 years. In the United 
States of America, between 1988 and 1994, the mean age of onset of type 2 diabetes was reported 
to be 52 years but this value has decreased to 46 years in the period 1999 to 2000 (Koopman et al, 
2005). The gap in the age of onset between developing and developed countries is closing down 
as the global age of onset of diabetes is in constant downward trend. 
In terms of monthly family income, 17% of the respondents did not provide any information 
regarding their income. This is viewed as sensitive information by lots of people in the study 
setting and as such, many prefer not to reveal the details of their income. Secondly, for many 
patients who earn money through informal means like subsistence farming, aids from relatives and 
friends, it is difficult to quantify the amount of income they receive and moreover, these means of 
income are not regular. For the remainder of the study population that provided information about 
their income, 11% were in the ‘high income’ category (> 200,000 Naira), 32% were in the ‘low 
income’ group (< 50,000 Naira) and 57% were in the ‘middle income’ category (50,000 to 200,000 
Naira). This goes to support the fact that diabetes is not (in contrast to the early and mid-20th 
century) a disease only for the wealthy communities (IDF, 2015) as most of the patients are either 
low or middle-income earners. This is reflected generally in the recent high prevalence of diabetes 
in LMICs. 
The educational profile of the study population shows that 8% had no formal education, 11% 
completed only primary education, 25% completed secondary and 56% had a post-secondary 
education. This is comparable to the educational level of a diabetic population studied by Adisa et 
al (2011) in which 9.6% of the patients had no formal education, 19.3% completed only primary 
education, 28.1% completed secondary while 43% had tertiary education. The high level of 
education amongst the respondents reflects the nature of Abuja as a metropolitan state where 
people from all regions of the country migrate to and naturally higher proportions of educated 
people live in the environs of our study hospitals. 
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Sixteen percent (16%) of the sampled population were unemployed, 20% were retired while 64% 
were employed. This is comparable to what was reported by Adisa et al (2009) in a study in south 
western Nigeria where 17% of the sampled diabetic patients were unemployed. On the other hand, 
Ababio et al (2017) in a study in two tertiary hospitals in Nigeria and Ghana reported a high 
unemployment rate (41%) amongst the diabetic population. Similarly, Al-Akour et al (2011) while 
studying the determinants of glycaemic control in type 2 diabetic patients in a tertiary hospital in 
Jordan, reported that 59.5% of the diabetic patients were unemployed. The relatively lower rate of 
unemployment in our study population may be as a result of the setting in which the hospital is 
located. A lot of the patients are educated and so may be the reason why a good number of them 
are employed. In comparison to the unemployment rate in the Nigerian population, the 
unemployment rate of 16% is slightly higher than in the general population (14%) (National 
Bureau of Statistics (NBS), 2017). This could be a reflection of the limitations imposed on these 
patients by diabetes. 
About 62% of the respondents were taking only oral antidiabetic medications. This is lower than 
figures reported in other studies (Yusuff, Obe, & Joseph, 2008; Chinenye et al, 2012) where over 
85% of the diabetic patients were on oral medications only. Twenty-eight percent of the diabetic 
patients sampled in the study were on combination therapy of insulin and oral medications. This 
is twice as much as the value reported in Yusuff et al (2008) and thrice that reported by Chinenye 
et al (2012). Only 8% of the respondents were on insulin-only therapy and this is comparable to 
the 9.9% reported by Chinenye et al (2012). The differences in the pattern of prescription seen in 
our study and that of other previous studies reflect an increased usage of insulin by medical 
practitioners in Nigeria and the increased acceptability of insulin usage by Nigerian diabetic 
patients (Ezeani et al, 2017) 
The average duration of diabetes treatment in the study was 9.2 years and this is consistent with 
the findings of Chinenye et al (2012) who reported a mean duration of diabetes treatment of 8.8 
years. This short duration of treatment may be because Nigerian diabetics do not live long enough 
to have a prolonged duration of treatment. They develop complications early which could be fatal. 
Comorbidities were found in 75% of the patients with hypertension being the most prevalent 
(64%). Struijs et al (2006) reported that 44% of diabetic outpatients visiting general practitioners 
(GP) in the Netherlands had at least one comorbidity. While this value may seem significantly 
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lower than of our study, it should be noted that GP clinics are not specialist clinics and as such 
complicated cases with possibly other comorbidities would have been referred to specialist clinics. 
Specialist clinics (like our study hospitals) are expected to have more complicated diabetic cases 
with more comorbidities. 
In comparison to other diabetic populations, our study population seem to be taking a lot more 
tablets. About 55% of our respondents are taking > 4 tablets per day. This is in sharp contrast to 
what was reported by Blüher et al (2015) in a large multicenter study of German diabetic patients 
where just 5.9% of the patients were on > 4 tablets per day. This discrepancy may be a result of 
more complications and comorbidities in the Nigerian diabetic patients necessitating the use of 
more medications. The greater availability of more fixed dose combinations of anti-diabetic 
medications in developed countries such as Germany may explain why the patients in these 
countries consume less number of tablets in the treatment of chronic diseases (Blüher et al, 2015). 
Insurance coverage for the sampled patients was poor. Only 6% of the respondents had a full 
insurance coverage. About a quarter of the patients had a partial insurance coverage while 70% 
had no form of health insurance. Other authors have reported insurance coverage of about 10% 
amongst diabetic patients in Nigeria (Fasanmade & Dagogo-Jack, 2015). In Africa, health 
insurance coverage is minimal or non-existent (Leive & Xu, 2008; Oguejiofor, Odenigbo & 
Onwukwe, 2014) compared to developed countries where coverage rates approach 100% (Bowker 
et al, 2004; Ellis, Chen & Luscombe, 2014). The weak insurance system in African countries may 
be a result of their lower income, poor health system or inefficient leadership. 
Thirty-four percent (34%) of the patients were obese (BMI ≥ 30 kg/m2) and this is twice the value 
reported in most hospital-based diabetes studies in Nigeria (Fasanmade & Dagogo-Jack, 2015). 
The mean BMI of the study population was 28.9 kg/m2 and this was slightly more than that 
reported by Chinenye et al (2012) (27.2kg/m2) in studying Nigerian diabetics in 6 different tertiary 
hospitals. In their study, Chinenye et al reported that only 35.9% of the diabetic patients adhered 
regularly to exercise as prescribed and 26.7% not exercising at all. This is in agreement with the 
findings in our study population in which 35% were found to be physically active. This is better 
than that reported in other diabetic populations (Chuang et al, 2002; Solberg et al, 2008). 
About one-third of the study population (34%) monitored their blood glucose at home on regular 
basis. Other Nigerian studies (Chinenye et al, 2012; Fasanmade & Dagogo-Jack, 2015) have 
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reported a lower rate of self-monitoring of blood glucose (27.2% and 25.4% respectively). This 
figure is still low as all diabetic patients are expected to monitor their blood glucose by themselves 
on a regular basis as this improves their level of glycaemic control. The possible reasons why most 
Nigerian diabetics are unable to monitor their blood glucose regularly includes the lack of health 
insurance coverage, inadequate patient counselling by healthcare provider and poverty. 
The high level of satisfaction expressed by the study population is in keeping with previous studies 
(Wredling et al, 1995; Redekop et al, 2002; Alazri & Neal, 2003). Generally, patients are often 
positive in evaluating their healthcare providers and reluctant to express dissatisfaction 
(Fitzpatrick, 1991; Baker & Streatfield, 1995; Grol et al, 2000). 
About a third of our study population did not follow a healthful eating plan within the last seven 
days. Chinenye et al (2012) reported that only 6.9% of their study population did not follow any 
eating plan but the timeline was not limited to seven days. Many diabetic patients in Nigeria 
assume that diabetic meals are expensive and do not bother to strictly adhere to these dietary 
requirements. They cannot afford to have a separate meal from that consumed by the rest of the 
family. It is possible that the patients are not aware of cheaper healthy meals for diabetic patients. 
The most prevalent diabetic complication in the study was retinopathy (37%). This retinopathy 
prevalence rate is in keeping with other Nigerian studies (Chinenye et al 2012, Oguejiofor et al, 
2014). The prevalence of peripheral neuropathy in the study by Chinenye et al (59.2%) was more 
than twice that of our study population (27%). In general, the high prevalence of complications in 
Nigerian diabetics is due to late diagnosis, poor adherence to treatment and lifestyle 
recommendations, limited access to care and therefore poor glycaemic control. The higher 
prevalence of coexisting comorbidities (like hypertension) in African diabetics also increases the 
chances of having more complications (especially microvascular) (Oguejiofor et al, 2014). 
5.2 Glycaemic Control 
The Glycaemic control of the participants was determined using HbA1c and FPG. HbA1c was 
given a priority because it is the gold standard for glycaemic control monitoring (Adebisi, 
Oghagbon, Akande & Olarinoye, 2009; WHO, 2011; ADA, 2017). A good glycaemic control was 
defined as patients who had HbA1c of < 7% according to the ADA guidelines (ADA, 2017). For 
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patients who had no HbA1c test result, an average FPG of < 126 mg/dl (from the latest 2 FPG 
measurements) was used as a criterion for good glycaemic control. 
About 74% of the participants had a recent HbA1c measurement and this represents a significant 
proportion when compared with other Nigerian studies where lower proportions of diabetics have 
a HbA1c measurement. Chinenye et al (2012) found only 49.5% of Nigerian diabetics to have a 
recent HbA1c measurement. Generally, only 5% of African diabetics have access to HbA1c 
measurement (Whiting, Hayes & Unwin, 2003). HbA1c is a relatively expensive investigation and 
the resource limitation often associated with African patients and healthcare system makes it 
difficult to provide this service at regular basis for diabetic patients. Several local glycaemic 
control studies are based on fasting plasma glucose assessment (Adisa et al, 2011). The higher 
level of HbA1c availability in this study could be attributed to the fact that our study hospitals are 
highly specialized tertiary healthcare institutions and naturally have more funding and expertise. 
Secondly, our participants are mainly of middle and high social class and can afford to perform 
the test as and when due. However, majority of diabetic patients are not cared for in such 
institutions but rather in primary and secondary health centres who often lack the facility to 
perform more expensive and or complex laboratory procedures like HbA1c. The glycaemic control 
of the remaining 24% of the respondents who had no HbA1c measurement was assessed using the 
average FPG. Both measurements were combined to yield a new variable-Glycaemic control- for 
all patients. 
The final analysis revealed that 53% of the participants had poor glycaemic control. Other Nigerian 
studies reported a poor glycaemic control rate between 60% and 70% (Adebisi et al, 2009; Adisa 
et al, 2011; Chinenye et al, 2012). The variance in the level of glycaemic control in Nigerian 
diabetics could be linked to the type of hospital where the patients were sampled, the laboratory 
parameter used in assessing the glycaemic control or the cut-off criteria used by the researchers. 
For example, Adebisi et al utilized a HbA1c cut-off of 7.2% and 64% of their participants had a 
HbA1c greater than 7.2% (poor glycaemic control). The higher cut-off (compared to our study) 
could increase the proportion of patients with good glycaemic control. Adisa et al (2011) assessed 
glycaemic control in diabetic patients attending a tertiary hospital in Ibadan, southwestern Nigeria 
using FPG ≤ 110 mg/dl as the cut-off criteria for good glycaemic control based on the United 
Kingdom Prospective Diabetes Study Group definition of intensive control for diabetes patients 
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(as FPG of less than 108 mg/dl) (UKPDs, 1998). This lower criterion of 110 mg/dl could explain 
why their rate of poor glycaemic control (60%) was higher than that of our study population. 
Chinenye et al (2012) utilized the same criterion as in our study (HbA1c >7%) to describe poor 
glycaemic control rate. In their multicenter study across Nigeria, 68% of the patients had poor 
glycaemic control. In the same study, they analysed glycaemic control using IDF target of 6.5% 
and the proportion of patients with poor glycaemic control rose to 80%. Their study spread across 
6 different geopolitical regions in Nigeria and may represent a better picture for the Nigeria 
diabetic patients and may explain the higher proportion of patients with poor glycaemic control 
even with similar criteria. 
In other African countries, high rate of poor glycaemic control (60% to 90%) has been consistently 
reported (Erasmus et al, 1999; Longo-Mbenza et al, 2008). The 53% rate of poor glycaemic in our 
study is comparable (and with similar criteria of HbA1c >7%) to that obtained in Jordan (Al-
Alkour, Khader & Alaoui, 2011), USA (Shaya et al, 2016) and Saudi Arabia (Al-Nuaim et al, 
1998).  
Modebe & Masoomi (1999) reported that 78.2% of Barhrani diabetic patients had poor glycaemic 
control but their paper did not clarify the exact criteria they used. A series of retrospective studies 
done in the United Kingdom revealed that 79% and 76% in 1998 and 2002 respectively of UK 
diabetic patients had poor glycaemic control (HbA1c cutoff > 7%) (Fox, Bolinder, Chen & Kumar, 
2006). 
An alternative way to picture the glycaemic control level of a diabetic population is to calculate 
the mean value for the HbA1c and/or the FPG. This way, one could avoid the extra hurdle of 
determining the exact criteria used by the researchers to classify patients into good or poor control 
and comparison between groups is easier. The average HbA1c of the diabetic patients that were 
sampled was 7.6% ± 2.4% and the mean FPG was 142 mg/dl ± 53.8 mg/dl. This is lower than the 
values reported by Chinenye et al (2012) while studying Nigerian diabetic patients-a mean HbA1c 
of 8.3% ± 2.2% and a mean FPG of 146 mg/dl ± 70 mg/dl. The diabetic patients studied by Adisa 
et al (2011) in Ibadan, Nigeria had a mean FPG of 139 mg/dl ± 71 mg/dl. Although the patients in 
our study had a better overall picture in terms of HbA1c, the level of glycaemic control is still far 
from the target value of 7%. The mean FPG values in the three Nigerian populations are 
comparable.  The reasons for poor glycaemic control amongst Nigerian diabetic patients include 
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financial limitation (Yusuff, Obe & Joseph, 2008; Adsia et al, 2011), high cost of diabetes 
medications (Adibe et al, 2009; Adisa, Alutundu & Fakeye, 2009) poor knowledge about the 
disease condition (Chinenye et al, 2012), inadequate diabetes care providers, absence of health 
insurance coverage (Fasanmade & Dagogo-Jack, 2015) and lack of effective diabetes policy 
implementation (Chinenye, Oputa & Oko-Jaja, 2014). 
The mean HbA1c in the study does not vary significantly with what was reported in diabetic 
patients in Kinshasa, Congo-7.4% ± 1.4% (Longo-Mbenza et al, 2008) but differed from what was 
seen in black South African diabetics attending diabetes clinic at a peri-urban hospital - 9.6% ± 
0.1% (Erasmus et al, 1999). In addition to the factors listed above that are responsible for the poor 
glycaemic control amongst Nigerian diabetics, sub-Saharan African countries generally have 
limited resources which are often shared between communicable and noncommunicable diseases 
(Longo-Mbenza et al, 2008). 
Ten of the interviewed patients (about 3% of the study population) had a HbA1c value of less than 
4%, which is subnormal considering that healthy persons without diabetes have a HbA1c 
concentration of 4-6% (Wiener 2001; Chu, Wang, Sun, Lee & Lam, 2007). Other studies 
considered a HbA1c value less than 4.7% as subnormal (Camargo & Gross, 2004). Six percent of 
our respondents (21 patients) had a HbA1c level of less than 4.7%. This rate is considerable higher 
than previously reported. Camargo & Gross (2004) while studying the causes of very low HbA1c 
among diabetic patients in a university hospital in Brazil reported that 0.4% (130 out of 29,657 
HbA1c measurements) of the entire study participants had a HbA1c of less than 4.7%. It is 
important to note that a very low or falling HbA1c level in a diabetic patient is not always a pointer 
to improving glycaemic control (Wiener, 2001). Measurement errors in the laboratory and clerical 
errors either by laboratory personnel or members of the management team who transfer laboratory 
values into patients’ case note must be conclusively excluded in cases of very low HbA1c. 
In the absence of measurement or clerical errors, abnormal variants of haemoglobin and alterations 
in the lifespan of red blood cells are significantly implicated in diabetic patients with very low 
HbA1c (Wiener, 2001; Camargo & Gross, 2004; Chu, Wang, Sun, Lee & Lam, 2007). Some 
abnormal variants of haemoglobin that can give a low HbA1c include HbAS, HbAD, HbAC and 
HbSC. Therefore, the haematological history of diabetic patients with very low HbA1c must be 
properly reviewed to rule out these haemoglobin variants. Some modern HbA1c measurement 
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techniques is not affected by these variants. The exact method of HbA1c measurement in our 
setting was not ascertained. HbA1c levels may also be reduced by alcoholism, lipaemia and 
chronic ingestion of salicylates and haemolysis causing drugs (Camargo & Gross, 2004). 
5.3 Socio-demographic Factors and Glycaemic Control 
 5.3.1 Age and Glycaemic Control 
There was no statistically significant difference in glycaemic control between different age groups 
but the trend shows worsening glycaemic control with increasing age.  Amongst the ‘50-59’ age 
group, 56% of them had poor glycaemic control while 52% of patients aged 60 years or more had 
poor glycaemic control. Half of the patients in the younger age group categories had a poor level 
of glycaemic control. Generally, previous studies reported no significant association between age 
groups of diabetic patients and the achievement of glycaemic control (Arai et al, 2009; Al-Akour, 
Khader & Alaoui, 2011) and the reported trends are not consistent across different literatures. 
While some studies reported better glycaemic control in younger age groups (Almutari, Said & 
Zainuddin, 2013), others reported better control in older age groups (Ahmad, Islahudin & 
Paraidathathu, 2014) 
 5.3.2 Gender and Glycaemic Control 
  There was no statistically significant difference in glycaemic control between the male (46% had 
good control) and female (48% had good control) diabetic patients. Other previous studies have 
also found no statistically significant difference in glycaemic control between the two gender 
groups (Al-Akour, Khader & Alaoui, 2011; Ahmad, Islahudin & Paraidathathu, 2014). The 
common trend in previous studies, although not statistically significant, is a better glycaemic 
control in female patients and this could be due to the higher rate of adherence to medications of 
female patients (Adisa et al, 2009). 
5.3.3 Marital Status and Glycaemic Control 
There was no statistically significant difference in glycaemic control between married patients 
(54% had poor control) and ‘not married’ patients (47%). Al-Akour et al (2011) also found no 
statistically significant difference in glycaemic control between the two groups although the trend 
is similar to that of our study (married patients having poorer control (53%) than ‘not married’ 
patients (48%)). Adisa et al (2011) found a significant correlation between adherence to 
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medications in diabetic patients and their marital status. In their report, widowed patients adhered 
better to their medications than married and single patients. With the exception of the two patients 
who were separated from their spouses, the rate of glycaemic control in our study seem to follow 
the trend reported by Adisa et al- widowed patients having a better glycaemic control (53% with 
good control) than married (46% with good control) and single (33% with good control). More 
recent studies found no association between marital status and glycaemic control (Yokobayashi et 
al, 2017). 
 5.3.4 Residence and Glycaemic control 
 No statistically significance difference in glycaemic control was observed between patients who 
reside in rural areas and those in urban areas. The trend shows however that the proportion of 
patients in rural settlements with poor glycaemic control is higher than those in urban settlements 
(55% vs 52% respectively). This finding is in keeping with the findings of other studies (Andrus 
et al, 2004). Rural patients are less likely to be diagnosed early due to lower probability of 
screening and diabetes prevention education. They often are less educated than their urban 
counterparts and so have a poorer understanding of the disease. Their access to healthcare service 
is often limited. Income level of rural patients are often lower (World Bank, 2014) and hence might 
not be able to afford their medications or to self-monitor their blood glucose or perform all the 
required laboratory tests. 
 5.3.5 Family history of diabetes and Glycaemic control 
Patients with positive family history had a higher rate of good glycaemic control (50% vs. 44%; 
p=0.226). Similarly, Al-Akour et al (2011) reported a better glycaemic control amongst diabetic 
patients with positive family history (49% vs. 46%; p=0.754). A possible explanation of this trend 
is the Health Belief Model which links up an individual’s behaviour to his/her perception about 
the seriousness of the disease, his/her susceptibility to the disease, perceived benefits and barriers 
(Munro et al, 2007). Patients with positive family history are more likely to perceive diabetes as 
being serious and perceive a higher level of susceptibility to diabetes and its complications (Munro 
et al, 2017). This would motivate them to adopt behaviours which would improve their level of 
glycaemic control. 
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5.3.6  Income and Glycaemic Control 
The worst glycaemic control was found in patients with high income (65% of them had poor 
glycaemic control) followed by those with middle income (53% of them had poor glycaemic 
control). This is in contrast to what has been reported in most studies (Delamater, 2006). The belief 
is that patients with high income is able to afford their medications and laboratory investigations. 
The possible explanation of the scenario in our study is that diabetes management goes beyond 
medication financeability. Diabetic patients must invest their time and energy in other behaviours 
like exercising regularly, weight loss and being dietary conscious. The high-income patients in our 
study might be found wanting in these behaviours much more than their counterparts with middle 
and low income. Secondly, 16.5% of the study population did not report income information and 
this missing income information was more prevalent in the unemployed group which led to an 
underrepresentation of unemployed individuals in the analyses. In addition, people in our study 
setting have some reservations regarding revealing their income and as such could provide a 
fictitious income information in the questionnaire. A good number of the patients also have an 
informal employment or self-employed and sometimes are not able to give an exact income 
information. 
 5.3.7 Education and Glycaemic Control  
An inverse relationship (although not statistically significant) exists between level of education 
and glycaemic control. Patients with highest level of education had the worst glycaemic control 
and vice versa. Al-Akour et al (2011) also documented a similar trend of statistically insignificant 
inverse proportionality between level of education and glycaemic control. Adisa et al (2011) 
reported that there is no significant association between educational status and glycaemic control.  
5.3.8 Employment and Glycaemic Control 
No significant association was found between employment status and glycaemic control. The rate 
of poor glycaemic control was highest amongst the ‘employed’ patients (54%) followed by retired 
(53%) and then ‘unemployed’ patients (49%). Comparably, Al-Akour et al (2011) reported that 
53% of the employed patients in their study had a poor glycaemic control while 51% of those who 
are not employed had a poor glycaemic control. This was also not statistically significant. In 
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contrast (and more understandably), Almutairi, Said & Zainuddin, (2013) stated that diabetic 
patients in Saudi Arabia without a job had worse glycaemic control and this was statistically 
significant. 
 5.3.9 Means of Financing Diabetes Treatment and Glycaemic Control 
The worst glycaemic control was found in patients whose treatment was financed through family 
support (61% with poor control). This was followed by patients with full health insurance (57%), 
partial insurance (52%) and the best glycaemic control was in patients who self-financed their 
treatment (49% of whom had poor control). This however was not statistically significant. This 
finding differs from the findings of other studies- insured patients have better glycaemic control 
(Karter et al, 2000; Bowker et al, 2004; Benoit et al, 2015). The possible reason for this discrepancy 
could be a poor structured health insurance system in Nigeria. Insured patients often have cost 
limitations on the type and quality of treatment they receive. Some drugs are not covered by the 
scheme and hence, the healthcare providers are forced to use certain drugs which often are the less 
preferred options. The patients who pay by themselves for their medications have the luxury of 
receiving the best possible treatment as far as they can afford them. Secondly, the number of 
patients with full health insurance was too small (6 patients) and this can influence the outcome of 
the analysis. 
5.4 Behavioural and Lifestyle-related Factors and Glycaemic Control 
 5.4.1 Adherence to Medication and Glycaemic control 
The association between medication adherence rate and glycaemic control was not significant. The 
best glycaemic control rate was found in the ‘Never’ and ‘Often’ group (52% respectively had 
good control). Patients who seldom or sometimes forget to take their medications had about 40% 
good glycaemic control rate. Similarly, there was no significant difference in the mean number of 
days that the patients consumed their medications in both outcome groups (Table 4.5). Although 
medication adherence is an important component of achieving glycaemic targets (Delamater, 
2006), some studies have found that even high levels of medication adherence does not equate to 
good glycaemic control (Adisa et al, 2011). Adherence to lifestyle/behavioural recommendation 
is more beneficial in glycaemic control. 
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5.4.2 Physical Activity and Glycaemic Control 
The difference in glycaemic control between ‘physically active’ (49% had good control) and 
‘physically inactive’ (46% had good control) diabetic patients was not statistically significant. 
Comparison of the mean number of days patients engaged in physical activity revealed that 
patients with good glycaemic control engaged in sport more frequently (2.99 days per week) than 
those with poor glycaemic control (2.52 days per week). Although these findings were not 
statistically significant, it reflects the stance of most studies (Boulé et al, 2001; Thomas, Elliott & 
Naughton, 2006; Sigal et al, 2007; Mikus et al, 2012;). Physically inactive patients are often 
overweight or obese and these are also independent risk factors for poor glycaemic control. 
Involvement of diabetic patients in regular physical activities promote good glycaemic control 
(Almutairi, Said & Zainuddin, 2013).  
5.4.3 Body Mass Index and Glycaemic Control 
There was no statistically significant difference in glycaemic control between obese diabetic 
patients and normal/overweight patients. Fifty-five percent (55%) of obese diabetic patients (BMI 
≥30 kg/m2) had poor glycaemic control while 53% of those who are either overweight or have a 
normal weight (BMI <30 kg/m2). The increased risk of poor glycaemic control in obese diabetic 
patients found in the study was not statistically significant but the observed trend is in agreement 
with the findings of Khattab et al (2010)-obese patients having the highest rate of poor glycaemic 
control of 69.5%- and Al-Akour et al (2011)- obese patients having also the highest rate of poor 
glycaemic control of 53.8%. The outcome of these two studies were also not statistically 
significant. Obesity has been reported to account for 80% of the risk of developing type 2 diabetes 
and obese people are 80 times more likely to develop type 2 diabetes than those with a BMI of less 
than 22 kg/m2 (European Association for the Study of Obesity, (EASO), 2016). This risk of 
diabetes onset associated with obese persons also accounts for the increased likelihood of obese 
diabetic patients having a poor glycaemic control. The exact mechanism through which obesity 
causes diabetes (or poor glycaemic control) is unclear but three key mechanisms have been 
proposed and they include- increased production of adipokines/cytokines, including tumor 
necrosis factor-α, resistin, and retinol-binding protein 4, that contribute to insulin resistance as well 
as reduced levels of adiponectin; ectopic fat deposition, particularly in the liver and perhaps also 
http://etd.uwc.ac.za
53 
 
in skeletal muscle, and the dysmetabolic sequelae; and mitochondrial dysfunction which decreases 
insulin sensitivity and compromises pancreatic βcell function (Eckel et al, 2011). 
 5.4.4 Self-monitoring of Blood Glucose and Glycaemic Control 
Patients who self-monitored their blood glucose more frequently (4-7 days per week) had a higher 
rate of poor glycaemic control (59%) compared to those who self-monitored their blood glucose 
less frequently (0-3 days per week) (49%). Similarly, when the mean number of days that the 
patients self-monitored their blood glucose were compared across the two groups of outcomes, 
patients with poor glycaemic control had a mean of 3.68 days while those with good glycaemic 
control had a mean of 3.21 days. The difference was not statistically significant in both analyses. 
However, Harris (2001) reported a similar trend between self-monitoring of blood glucose among 
diabetic patients and their level of glycaemic control. In his study, the HbA1c value was found to 
be directly proportional to the frequency of self-monitoring of blood glucose. This finding suggests 
that patients with poorer glycaemic control have a greater tendency to self-monitor. The patients 
with poorer level of glycaemic control are more likely to use insulin injections and as such, must 
self-monitor their blood glucose to avoid dose-related insulin complications. 
 5.4.5 Adherence to Healthful Eating Plan and Glycaemic Control 
This variable was found to be statistically significant in both types of analyses done (categorical 
and mean comparison (Table 4.3; Table 4.5). The ‘non-adherence’ category (those who adhered 
to a healthful eating plan 0-1 day per week) had the highest level of poor glycaemic control-64% 
(p=0.036). The other three categories- good adherence (6-7 days/week), moderate adherence (4-5 
days/week) and poor adherence (2-3 days/week)- had a poor glycaemic control rate of 47%, 47% 
and 46% respectively (Table 4.5). 
In comparing the mean number of days patients adhered to a healthful eating plan across the two 
outcome groups (good glycaemic vs poor glycaemic control), a statistically significant difference 
was found as the patients with good glycaemic control were seen to have followed a healthful 
eating plan on more number of days (4.38 days) compared to those who had poor glycaemic control 
(3.47 days) (p=0.017) (Table 4.5). The importance of diet in the management of diabetes cannot 
be overemphasized as demonstrated by several publications (Almutari, Said & Zainuddin, 2013; 
ADA, 2017). A healthful eating plan includes diets which are low in fat and carbohydrate and high 
http://etd.uwc.ac.za
54 
 
in fibre content and such plan when included in the management plan of diabetic patients, often 
leads to improved glycaemic control (UKPDS, 1998). The Mediterranean diet (Esposito et al, 
2009), the DASH diet (Cespedes et al, 2016) and plant-based diets (Rinaldi et al, 2016) are good 
examples of healthful eating patterns that has been shown to improve glycaemic control among 
diabetic patients. These dietary patterns could serve as a model for dietary planning in diabetes 
management. 
A collaborative development of an individualized eating plan-medical nutrition therapy (MNT)- 
is a key recommendation by the American Diabetes Association for the management of patients 
with diabetes (Inzucchi et al, 2015; ADA, 2017). The medical nutrition therapy is aimed at 
promoting and supporting healthful eating patterns, addressing the dietary needs of patients based 
on personal and cultural preferences, maintaining the pleasure of eating by providing 
nonjudgmental messages about food choices and providing the patients with practical tools for 
developing healthy eating patterns (Evert et al, 2014, ADA, 2017). A medical nutrition therapy 
administered by a registered dietician who is knowledgeable and skilled in dietary treatment of 
diabetes is more efficient and has been shown to lower HbA1c values in both type 1(Rossi et al, 
2010 & Scavone et al, 2010) and type 2 diabetes (UKPDS, 1998; Ziemer et al, 2003; Wolf et al, 
2004 & Coppell et al 2009). Making dietary decisions can be quite challenging for diabetic patients 
and they need the support of the health care team at every stage of the illness especially at the 
onset. Each member of the health care team should be well informed on the basic principles of 
medical nutrition therapy (ADA, 2017).  
Designing a healthful eating plan for diabetic patients is one thing and adhering to this plan is 
another. In our setting only 48.6% of the respondents adhered strictly to a healthful eating plan 
(good adherence group- followed a healthful eating plan for 6-7 days in the last week) although 
95% of the participants admitted that they have been counselled by their healthcare provider 
regarding choice of diet in their management. The quality of this dietary counselling could not be 
established. However, counselling done by medical doctors or nurses who are not trained to be 
dieticians are likely not going to be as efficient as that done by professional dieticians who are 
knowledgeable in the nutritional management of diabetes (ADA, 2017). The patients’ poor 
adherence to a healthful eating plan could also be due to patients’ poor interpretation of what a 
healthful diet should be (Bisogni, Jastran, Seligson & Thompson, 2012). Some diabetic patients 
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believe that a healthful diet is an expensive diet and so make no effort in trying to adhere to such 
nutritional recommendation. A proper patient education is required to address this problem and 
the ADA dietary guidelines (ADA, 2017) provides the basic framework that should be adopted in 
educating the patients on what their dietary plan should be.  
 5.4.6 Consumption of Fruits and Vegetables and Glycaemic Control 
The mean number of days that patients consumed adequate amounts of fruits and vegetables was 
compared across the two outcome groups (good vs poor glycaemic control) (Table 4.5) and a 
statistically significant difference was found to exist between the two groups. Patients with good 
glycaemic control consumed on the average adequate amount of fruits and/or vegetables on more 
days than those with poor control. Fruits and vegetables in general, are sources of fibre, minerals, 
vitamins, antioxidants and phenolics. Although the definitive roles of these substances are unclear, 
they help in the reduction of serum lipids and prevent oxidative damages to the body cells (Jenkins 
et al, 2011). Over time, they reduce cardiovascular complications of diabetes by improving 
glycaemic control in diabetic patients (Jenkins et al, 2011). The fibre in fruits and vegetables makes 
it more difficult for digestive enzymes to break down the starches into glucose. This leads to lower, 
slower increases in blood sugar and insulin, and a lower glycemic index. This reduces the stress 
on the body’s insulin-producing machinery, and so may help prevent type 2 diabetes or improve 
control in those already suffering from the disease (Villegas et al, 2007). Fruits and vegetables 
consumption is the most reliable index in accessing the general quality of diet consumed by 
individuals (Hendrie & Noakes, 2017). 
When analysed as a categorical data, no significant association was found between fruit and 
vegetable consumption and glycaemic control. However, the highest rate of poor glycaemic 
control (67%) was seen in patients who seldom consumed fruits and vegetables (0-1 day per week) 
while the lowest rate of poor glycaemic control (47%) was seen in patients who consumed fruits 
and vegetables regularly (6-7 days per week) (Table 4.3). This is consistent with several studies 
which have demonstrated that diabetic patients who consume fruits and vegetables on a regular 
basis have better glycaemic control than those who don’t (Franz et al, 2003). 
Despite the proven efficacy of the consumption of fruits and vegetables, its consumption is 
generally not optimal in Sub-Saharan Africa (Chubike, Okaka & Okoli, 2013; Silva, Ayankogbe, 
& Odugbemi, 2017). The WHO recommended quantity of fruits and vegetables to be consumed 
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daily of 400g/day (equivalent to 5 portions) is a tall order for most African countries (Nishida, 
Uauy, Kumanyika & Shetty, 2004). Only about 33% of the study population consumed adequate 
fruits and vegetables regularly (at least 5 portions of fruits and vegetables daily for the last 7 days) 
and this can be traced to several factors including cost, seasonal variations in availability, lack of 
knowledge about the potential benefits of consuming adequate amounts of fruits and vegetables 
and lack of satisfaction from consumption of fruits and vegetables (Silva, Ayankogbe, & 
Odugbemi, 2017). 
 5.4.7 Avoidance of High fatty foods and Glycaemic control 
The mean number of days that diabetic patients abstained from high fatty foods such as red meat 
and full cream dairy foods were compared across the two outcome groups and a significant 
difference was observed between the two groups. Patients with good glycaemic control avoided 
high fatty diets on the average, more frequently (mean number of days= 5.39) than patients with 
poor glycaemic control (mean number of days= 4.97) (Table 4.5). 
Excessive consumption of foods rich in saturated fats are major risk factors for dyslipidemia 
amongst diabetic patients (Lichtenstein et al, 2006). Dyslipidemia makes glycaemic control more 
difficult in diabetic patients and increases the risk of diabetic complications (especially 
cardiovascular complications). Stern et al (1992) observed that the prevalence of dyslipidemia in 
diabetic patients increased with worsening glycaemic control rate. Similarly, a significant 
association has been reported between HbA1c and serum lipids (Khan, Sobki & Khan, 2007) 
The consumption of red meat (pork, beef, lamb) and processed red meat (bacon, hot dogs, deli 
meats) increases the risk of diabetes (Harvard School of Public Health (HSPH), 2016). Daily 
consumption of 3-ounce of red meat increases the risk of type 2 diabetes by 20%. A daily 
consumption of 2 slices of bacon or one hot dog increases diabetes risk by 51% (HSPH, 2016). 
The mechanism through which red meat causes diabetes is uncertain but the high iron content of 
red meat has been highly implicated (HSPH, 2016). The iron diminishes the effectiveness of 
insulin and damages the islet cells that produce insulin. In processing meats, high levels of sodium 
and nitrites are used as preservatives and these elements may increase the risk of diabetes (HSPH, 
2016). This risk persists in patients who develop the disease and makes the control of their level 
of glycaemia more challenging. 
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Alternative and healthier sources of fat should be offered to the patients in the clinic. For example, 
the use of olive oil, which is the main source of fat in the Mediterranean diet (Esposito et al, 2009) 
could be a healthier option for the patient rather than other fatty foods and oils. The concept of 
DASH diet (Cespedes et al, 2016) and plant-based diets (Rinaldi et al, 2016) can also be discussed 
with the patient. Most importantly, the dietary specifications must be tailored to the patient and 
she/he must find the plan acceptable. 
 5.4.8 Even Spacing of Carbohydrate and Glycaemic Control 
On the average, patients with good glycaemic control more frequently spaced their carbohydrate 
meals (mean number of days=4.64) than their counterparts with poor glycaemic control (mean 
number of days= 4.31). This difference was not statistically significant (Table 4.5). Consistency 
in carbohydrate intake and spacing help in blood sugar control and weight management (Canadian 
Diabetes Association, 2013) in diabetic patients. 
5.5 Nature of Diabetes Treatment and Glycaemic Control 
 5.5.1 Type of treatment and Glycaemic Control 
Patients who are being treated with a combination of insulin injections and oral medication had 
the highest rate of poor glycaemic control (65%). This is followed by patients on either insulin 
(48%) or oral medications (49%) only. Seven patients were not on any medications but rather 
being managed by non-pharmacologically or lifestyle modification. Two of these patients had a 
poor glycaemic control. This finding was statistically significant but the small number of patients 
in the ‘no specific treatment’ group and the ‘non-pharmacological’ group could have influenced 
this statistic (Table 4.4). In comparison, patients on insulin-only treatment was reported by Harris 
(2011) to have the worst rate of poor glycaemic control (51.4%) compared to those on oral-only 
treatment (42.2%) and dietary management (14.9%).  
The reason why patients on insulin generally have worse glycaemic control could be traced to 
reduced probability of adherence (due to needle phobia), cost of insulin and means of insulin 
storage. Due to the epileptic nature of electricity supply in Nigeria, patients might not be able to 
store their insulin in the appropriate temperature and the potency of the insulin is often 
questionable after some days of purchase. Sometimes the storage shortfalls can be traced to the 
pharmacy outlet dispensing the insulin. Secondly the fact that patients are on insulin could signal 
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that patients are already in advanced stages of the disease with complications and as such more 
difficult to control blood glucose. This is more likely in our setting because insulin use by diabetic 
patients are often started very late due to both prescriber-related and patient-related factors (Sorli 
& Heile, 2014). Chinenye et al (2012) reported that only 20% of Nigerian diabetics had a 
prescription of insulin injection. 
 5.5.2 Pill Burden and Glycaemic Control 
Forty-eight percent (48%) of patients on more than 5 tablets per day had poor glycaemic control 
whereas 55% of the patients on less than or equal to 5 tablets per day had poor glycaemic control 
(Table 4.4; Figure 4.10). The higher rate of poor glycaemic control found in the patients who take 
fewer number of tablets was not statistically significant. In contrast to our finding, Donnan, 
MacDonald & Morris (2002) reported that diabetic patients on one tablet per day had better 
adherence rates (and better glycaemic control) than patients on multiple tablets. They also found a 
linear trend between the number of tablets and the level of adherence. Dezii et al (2002) also 
evaluated the rate of adherence of type 2 diabetic patients to glipizide prescription and found that 
patients on once-daily dosing adhered better than those with twice daily dosing although the 
adherence rate for both groups were suboptimal. The rate of adherence of patients to treatment 
regimens is directly proportional to the level of glycaemic control.  
A possible argument to explain the better glycaemic control in patients taking more than 5 tablets 
per day is that these patients are more likely to be on different drugs with different mechanisms of 
action that act synergistically to control blood glucose. Polypharmacy in diabetic patients could be 
a signal for possible comorbidities and such patients might be more inclined to adopt healthier 
lifestyles because of their different perception of the disease and their susceptibility to its 
complications. 
 5.5.3 Patients’ Satisfaction and Glycaemic Control 
A significant association was found between glycaemic control and the level of patients’ 
satisfaction with the healthcare provider. A greater percentage of dissatisfied patients (70%) had 
poor glycaemic control compared to the satisfied patients (51%). This is consistent with findings 
of Alazri & Neal (2003), who reported an association between patients’ satisfaction and outcome 
in diabetes-HbA1c. They submitted that steps taken to increase patients’ satisfaction (by 
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actualisation of their values and expectations) improve outcome by increasing compliance and 
adherence to treatment regimens. Satisfied patients therefore have better glycaemic control. There 
is also the chicken or the egg dilemma in this argument. Could it be the good glycaemic control 
achieved in certain patients that make them satisfied?  
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CHAPTER 6: CONCLUSION AND RECOMMENDATIONS 
6.1 Conclusion 
In this study, the sociodemographic, behavioural and treatment-related factors responsible for poor 
glycaemic control among adult type 2 diabetic patients attending follow-up clinics in two tertiary 
hospitals in Abuja, Nigeria were explored. The mean age of the patients sampled was 54 years and 
60% of them were females. Majority of the patients (47%) were middle income earners and have 
completed tertiary education (56%). Most of the patients were employed (63%) and about three 
quarter of them resided in urban settings. Just above 50% of the patients had a positive family 
history. Two thirds of the diabetic patients sampled were being treated with only oral medications 
while 8% are on insulin-only treatment. Twenty-eight percent (28%) are on a combination regimen 
of oral medications and insulin injection. Seventy-five percent of the patients had other 
comorbidities especially hypertension and dyslipidemia. The average pill load of the patients on 
oral medications was 4.8 tablets per day. About 70% of the patients had no health insurance 
coverage. Amongst those who were insured, only a quarter of them had a full comprehensive 
coverage. The mean BMI and waist circumference of the study population was 28.9 kg/m2 and 
97.6cm respectively. About 35% of the patients were physically active and only 34% of the 
respondents had done daily self-monitoring of blood glucose in the past one week. The level of 
satisfaction was high with 91% of the patients being happy with the services they received from 
their healthcare provider. 
HbA1c and FPG were used to assess the level of glycaemic control in the patients. About 74% of 
the study population had a HbA1c test result not older than 6 months. For this group of patients, a 
HbA1c of less than 7% was regarded as poor glycaemic control based on the American Diabetes 
Association diabetes protocol. The mean HbA1c of the participants was 7.6% and the value ranged 
from 3% to 15.3%. For the rest of the participants who had no recent HbA1c test result, the average 
of their latest two fasting plasma glucose measurements was used to ascertain their level of 
glycaemic control. Average FPG of greater than or equal to 126mg/dl was regarded as poorly 
controlled glycaemia. The average FPG of the sampled patients was 142mg/dl ranging from 
63mg/dl to 423mg/dl. When collected together (HbA1c- and FPG- based glycaemic control), 53% 
of the patients were found to have poor level of glycaemic control. 
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Although none of the socio-demographic characteristics examined (age, gender, marital status, 
residence, family history, income, education, employment and means of financing diabetes 
treatment) were found to have a statistically significant association with the level of glycaemic 
control, the trend seen in most of the variables were consistent with the findings of other similar 
studies. Poor glycaemic control was found to be more prevalent in extremes of ages (20-29 and 
70-79 age groups), males, married patients and patients living in rural areas. Patients without 
family history of diabetes had worse glycaemic control than those with a positive family history. 
Poor glycaemic control was also most prevalent in high income patients, those who have 
completed tertiary education and those who are employed. Paradoxically, patients with full health 
insurance coverage had the worst glycaemic control followed by those who pay out-of-pocket 
(either family or self). 
Some of the lifestyle/behavioural factors considered in this study were adherence to medication, 
physical activity, healthy diet and self-monitoring of blood glucose. The body mass index was also 
assessed in terms of how it affects glycaemic control. Amongst all these variables, only dietary 
behaviours were found to have a statistically significant correlation with glycaemic control. The 
remaining lifestyle variables showed expected relationship patterns with glycaemic control but the 
differences observed in both outcome groups were not statistically significant. 
The study showed that appropriate dietary habits is a very significant factor in the control of 
glycaemia in diabetic patients. Patients with the worst adherence rate to a healthful eating plan had 
the worst level of glycaemic control. Patients with poor glycaemic control averagely adhered to a 
healthful eating plan less frequently than patients with good control. Inadequate consumption of 
fruits and vegetables was seen to be a significant risk factor for poor glycaemic control. 
Consumption of foods high in fat content also conferred a significant risk of poor glycaemic 
control on diabetic patients. 
A statistically non-significant but important association was found between physical activity and 
glycaemic control. Patients with poor glycaemic control were observed to have engaged in 
physical activity less frequently than those who had good control. Patients with poor glycaemic 
control adhered more frequently to their medications and self-monitored their blood glucose more 
frequently. This observed difference, however was not statistically significant. 
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The nature of diabetes treatment (type/route of administration, pill burden) and level of satisfaction 
was also assessed for their role in glycaemic control of diabetic patients. Patients on a combination 
of oral medications and insulin had worse glycaemic control compared to ‘insulin-only’ or ‘oral-
only’ group and this finding was significant. Patients on ≤ 5 tablets/day had worse glycaemic 
control compared to those on > 5 tablets per day but this was not statistically significant. A 
significant association was found between level of satisfaction and glycaemic control as patients 
who were dissatisfied with the services of the hospital had a higher rate of poor glycaemic control. 
Some of the limitations of the study include, the use of different criteria for estimation of glycaemic 
control, the collection of data around a festive season, high probability of a non-response bias due 
to frequent data collection in the study clinics and the inability to make causal inferences from the 
study due to lack of temporality between the outcome and exposure. 
6.2 Recommendations 
Having established that socio-economic, behavioural and treatment related factors all influence 
glycaemic control, concerted efforts should be geared towards a comprehensive approach in 
solving the problem of poor glycaemic control amongst diabetic patients. The patient and the 
health care provider have a role to play. 
 The first problem is the need to monitor and control the glycaemic control of diabetic patients on 
regular bases. Diabetic patients should never be managed without regular follow ups. It is 
understandable that many patients travel long distances in order to attend follow up diabetes clinics 
and hence present to their doctors seldomly. A solution to this problem would be to adapt the 
chronic care model for the management of diabetes in primary settings (ADA, 2017). This model 
integrates several components of the health system in an effort to improve the quality of care 
received by chronic disease patients and it comprises 6 core elements- delivery system design, 
self-management support, decision support, clinical information systems, community resources 
and policies and health systems. At the very center of this model is the role of the healthcare 
delivery team and empowering patient self-management. The measurement of the HbA1c level 
must be taken seriously by both the managing team and the patient. It is recommended that patients 
whose blood glucose level is stable should have at least HbA1c test done every 6 months (ADA, 
2017). This should be increased to 4 times a year if therapy is adjusted or glycaemic control is not 
optimal (ADA, 2017). This regular monitoring makes it possible for timely treatment modification. 
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In instances where it is not possible to measure the HbA1c, the fasting plasma glucose, post-
prandial glucose measurement and glucose tolerance test could be used as a means to monitor the 
glycaemic control. However, the managing team must be aware of the limitations of using only 
plasma glucose measurement as a tool for glucose monitoring. Health care institutions managing 
diabetic patients should make efforts to acquire the equipment necessary to measure the HbA1c in 
addition to the other devices needed in the monitoring of treatment and complications. Patients 
who cannot afford the tests could join Diabetes clubs which in some instances, are able to sponsor 
some of these laboratory investigations and medications. Hospitals should also make efforts to 
subsidize the general costs of managing diabetes. The political hierarchy should review laws 
relating to healthcare financing in order to improve the supply of medicines at prices which are 
comparable to international prices. Medicines used in the treatment of chronic diseases like 
diabetes should be imported with little or no duties or taxes. This would help to reduce the burden 
of cost on the patients. A decent health insurance policy that includes all members of the society 
should be developed and implemented to ensure that patients are not well monitored due to 
financial reasons. 
The eating plan of every diabetic patient must be individualized and discussed immediately after 
diagnosis of diabetes (ADA, 2017). A registered dietician who is knowledgeable about the medical 
nutrition therapy in diabetes management is in the best position to provide the dietary counselling 
(ADA, 2017). A written dietary plan should be made available for the patient and the patients must 
be asked about this written plan at subsequent visits. It should be adjusted based on patients’ 
preferences (within accepted limits), seasonal availability of food, affordability, social and cultural 
background. 
Healthcare providers should develop mechanisms for monitoring patients’ adherence to treatment 
regimens- medications and lifestyle. An electronic monitoring system could be used to send 
reminders to patients about their follow-up appointments and also to educate them constantly on 
healthy lifestyles. Dietary guidelines and physical activity recommendations could be made 
available to patients in handbook or pamphlet formats or even phone applications.  
Health care providers should conduct researches on possible ways of improving the glycaemic 
control of their patients. They should also develop a guideline which is tailored to the peculiar 
needs of their institution and these guidelines must be updated at regular intervals to ensure that 
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its contents are in line with current best practices. All members of the healthcare team must also 
be conversant with the guideline to ensure uniformity of care for all patients.  
The healthcare team must operate based on the principle of collaboration amongst different 
diabetes experts. The diabetes management team must comprise health promoters and educators, 
endocrinologists, psychologists, and other specialists that may be needed at different times to 
manage complications arising from diabetes. Regular joint meetings should be organised by the 
managing team to discuss cases and review approaches to management. These meetings should 
sometimes involve the patients. The healthcare providers should collaborate with public health 
promoters in organising programmes aimed at improving the diet of the population. Such 
programmes should build partnerships across different government departments and parastatals 
and across different levels of healthcare. They should aim to inform the population on the benefits 
of whole grains and non-starchy vegetables as against refined carbohydrates and starches. Through 
these programmes, the population (and also diabetic patients) would understand how and why they 
need to cut down on salt and fat consumption or why the consumption of fruits and vegetables is 
essential. The people should also be made to know that the quality of food they eat is more 
important than the quantity.  
Healthcare providers should understand that the time allocated for each diabetic patient on their 
follow-up clinic days is insufficient for counselling the patients on lifestyle modifications and 
behaviours that can improve glycaemic control. Through these collaborations with health 
promoters, the healthcare provider could create another avenue for these patients to be counselled 
more adequately. These campaigns for healthy lifestyles should be popularized not only in 
traditional media (prints, television, radio) but also in social media which is fast becoming the 
choice media for information dissemination. Extensive health education is also a possible means 
to help improve glycaemic control. This will help in transforming some of the cultural beliefs of 
the people regarding diabetes. Certain portion of the Nigerian population still hold the view that 
obesity is a sign of good living and such is accepted. Through efficient education, such beliefs 
could be reduced or eliminated. A registered dietician should be part of every diabetes management 
team and a regular consultation with a dietician is as necessary as that with an endocrinologist. 
The most important member of the diabetes management team is the patient. No matter how 
diligent the efforts of other members of the team are, their success depends solely on the 
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willingness of the patient to accept their recommendations and follow their treatment plan. I 
therefore recommend that patients should be involved in their management at every step. They 
should not hesitate to ask questions regarding their illness and must strive to find ways to adhere 
to the treatment regimen. They should always see themselves as the protagonist in their 
management.  
In all these, what is clear is that everybody has a role to play in the improvement of glycaemic 
control amongst diabetic patients. 
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Appendix 1 
 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za  
 
PARTICIPANT INFORMATION SHEET 
Hello, 
1. Information about the Interviewer 
I am Ekene Casmir Igboerika, a student of the School of Public health, University of the 
Western Cape, South Africa. As part of my Masters in Public Health, I am required to conduct 
research aimed at evaluating the socio-economic and behavioural factors associated with poor 
glycemic control among adult type 2 diabetic patients attending outpatient diabetic clinics in 
tertiary hospitals in Abuja, Nigeria. In this study, I will also explore other factors associated 
with poor glycemic control. I can be contacted on this email- ekeneigboerika@gmail.com and 
this phone number- +2348038911940. 
2. Purpose and Contents of the Interview 
The purpose of this study is to describe the level of glycaemic control among adult type 2 
diabetic patients in Abuja and identify factors (socio-economic, behavioural and treatment-
related factors) associated with poor glycemic control in these patients 
3. Selection and Benefits 
Please understand that your participation is voluntary and you are not being forced to take part 
in this study. We are seeking your participation because we are using the outpatient diabetes 
clinic in your hospital. We are doing this in the two tertiary hospitals in Abuja National Hospital 
and University of Abuja Teaching Hospital. After compiling the responses from all participants, 
we hope to learn more about the factors that influence glycemic control among adult type 2 
diabetic patients in Abuja, which will help us, make useful recommendations to the relevant 
authorities and organizations 
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4. Risks and Withdrawal 
I do not anticipate any adverse effects emanating from the interview. Some of the questions 
might be sensitive so please feel free to skip questions you would prefer not to answer. You 
may however withdraw from the study at any time if you no longer wish to participate. There 
will be no penalties and you will not be prejudiced in any way.  
5. Confidentiality 
You will be asked questions about your socio-economic characteristics, behavioural lifestyle 
and other questions that are related to your diabetes treatment. I will not be recording your name 
anywhere on the questionnaire, and no one will be able to link you to the answers you give. 
Only researchers will have access to the unlinked information. All individual information will 
remain confidential. 
6. What if I have questions? 
This research is being conducted by Ekene Casmir Igboerika, a student of the School of Public 
Health, University of the Western Cape. If you have any questions about the research study 
itself, please contact Ekene Casmir Igboerika, at ekeneigboerika@gmail.com and/or 
+2348085388430. 
Should you have any questions regarding this study and your rights as a research participant 
or if you wish to report any problems you have experienced related to the study, please contact: 
Prof Helen Schneider 
Director of the School of Public Health 
University of the Western Cape 
Private Bag X17 
Bellville 7535 
hschneider@uwc.ac.za  
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za      
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This research has been approved by the University of the Western Cape’s Senate Research 
Committee. (REFERENCE NUMBER: BM/17/1/16) 
 
7. CONSENT 
I hereby agree to participate in research regarding the factors that are associated with poor 
glycemic control among adult type 2 diabetic patients attending outpatient diabetes clinics in 
tertiary hospitals in Abuja. I understand that I am participating freely and without being forced 
in any way to do so. I also understand that I can stop this interview at any point should I lose 
interest and that this decision will not in any way affect me negatively. 
The purpose of the study has been explained to me and I understand what is expected of my 
participation. I understand that this is a research project whose purpose is not necessarily to 
benefit me personally. I have received the telephone number of the researcher in case I need to 
speak about any issues that may arise in this interview. I understand that this consent form will 
not be linked to the questionnaire, and that my answers will remain confidential 
 
__________________ _________________________ 
Signature of Participant Date 
 
 
(I acknowledge the University of the Witwatersrand, Johannesburg, and anonymous members of the HSRC Research Ethics 
Committee for providing a framework for this Participant information form) 
http://etd.uwc.ac.za
81 
 
Appendix 2 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
INFORMED CONSENT: 
Title of Research Project: The Socio-Economic and Behavioural Factors Associated with Poor 
Glycaemic Control Among Adult Type 2 Diabetic Patients Attending the Outpatient Diabetes 
Clinic in Tertiary Hospitals in Abuja, Nigeria 
 
The study has been described to me in language that I understand. My questions about the study 
have been answered. I understand what my participation will involve and I agree to participate of 
my own choice and free will.  I understand that my identity will not be disclosed to anyone. I 
understand that I may withdraw from the study at any time without giving a reason and without 
fear of negative consequences or loss of benefits.    
 
Participant’s name………………………........................................ 
Participant’s signature……………………………….            
Date……………………… 
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Appendix 3 
 
 Questionnaire for the study on the Socio-economic and Behavioural Factors 
Associated with Poor Glycemic Control Among Adult Type 2 Diabetic 
Patients Attending the Outpatient Diabetes Clinic in Tertiary Hospitals in 
Abuja, Nigeria 
 
Questionnaire Reference Number    
 
 
A. Demography (Please check the appropriate box and fill in appropriate answers) 
 
1. Age (years)_______________ 
2. Hospital where you attend follow-up visits 
 a. National Hospital 
 b. University of Abuja Teaching Hospital 
3. Gender 
 a. Male 
 b. Female 
4. Marital Status 
 a. Single 
 b. Married 
 c. Divorced 
 d. Widowed 
 e. Separated 
5. Ethnic Group 
 a. Hausa 
 b. Fulani 
 c. Yoruba 
 d. Igbo 
 e. Other (specify): ___________________ 
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6. Residence 
 a. Urban 
 b. Rural 
 c. Semi urban 
 d. Informal Settlements 
 
B. Diabetes Related Variables (Please check the appropriate box and fill in 
appropriate answers) 
 
7. Age at first diagnosis of Diabetes ____________ 
8. Do you have any family history of diabetes? (Please check all that apply) 
 a. Parent(s) 
 b. Any Sibling 
 c. Other Relatives 
 d. None 
 e. Unknown 
9. Latest Glycated Haemoglobin (HbA1c) value _______________ 
10. Value of last two fasting plasma glucose results (in mg/dl) 
a. ____________ 
b. ____________ 
c. Average______________ 
11. Nature of Diabetes Treatment 
 a. Non-Pharmacological (Lifestyle modifications)  
 b. Oral Medication alone  
 c. Insulin injections alone  
 d. Combination of Insulin and Oral Medications 
 e. No specific treatment  
12. How long have you been on treatment for diabetes generally? ___________ 
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C. Socio-economic Variables (Please check the appropriate box and fill in 
appropriate answers) 
 
13. What is the average total combined monthly income of all members of your family? 
 a. Less than 20,000 Naira 
 b. 20,000 to 50,000 Naira 
 c. 51,000 to 100,000 Naira 
 d. 101,000 to 200,000 Naira 
 e. 201,000 to 500,000 Naira 
 f. Greater than 500,000 Naira 
14. What is the highest level of education you have completed? 
 a. No education at all 
 b. Primary school 
 c. Secondary school  
 d. University or post-school qualification  
15. Concerning employment, which of these is applicable to you?  
 a. Unemployed  
 b. Government Employee  
 c. Non-Government Employee  
 d. Self-Employed  
 e. Employer  
 f. Retired 
16. What is the nature of your job? 
 a. Legislator, senior official or manager  
 b. Professional, Technician, or associate Professional  
 c. Clerical  
 d. Personal Services, Marketing, or Sales  
 e. Agricultural or Fisheries Worker  
 f. Craft, Construction, or Trades  
 g. Plant and Machine Operators or Assemblers  
 h. Armed Forces  
 i. Others (specify) ___________________________________ 
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D. Treatment Related Variables (Please check the appropriate box and fill in 
appropriate answers) 
 
17. List all the drugs (for treatment of any disease) you take daily. If you inject insulin, 
include that in the list as well 
a. ________________________________ g. ___________________________ 
b. ________________________________ h. ___________________________ 
c. ________________________________ i. ___________________________ 
d. ________________________________ j. ___________________________ 
e. ________________________________ k. ___________________________ 
f. ________________________________ l. ___________________________ 
18. Are you on treatment for any of these diseases in addition to diabetes? 
 a. Hypertension 
 b. Dyslipidemia 
 c. Cardiac Failure 
 d. Osteoarthritis 
 e. Other (specify):  _________________________ 
 f. None 
19. What is the average total number of tablets of medicines you take daily? __________ 
20. What is the average monthly cost of your medications? __________________ 
21. How do you finance the payment for your treatment? 
 a. Fully paid by insurance 
 b. Partially paid by insurance 
 c. Self-payment (out-of-pocket)  
 d. Family sponsored 
22. How often do you not take your medication? 
 a. Never 
 b. Seldom (once per month)  
 c. Sometimes (once per week)  
 d. Often (more than once per week)  
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23. What is your main reason for not taking your medication? 
 a. Forgetfulness 
 b. Financial constraints 
 c. Prescribed drugs not available at the pharmacy stores 
 d. The drugs are not effective in controlling my blood sugar 
 e. Lack of explanation by the healthcare provider 
 f. Side effects of the drugs 
 
E. Diabetes Self-care Factors (circle the corresponding number) 
 
Exercise 
24. On how many of the LAST SEVEN DAYS did you participate for at least 30 minutes 
of physical activity (total minutes of continuous activity including walking)  
 0 1 2 3  4  5  6  7 
25. On how many of the LAST SEVEN DAYS did you participate in any specific 
exercise session (such as swimming, biking, walking) other than what you do around 
the house or as part of your work? 
 0 1 2 3  4  5  6  7 
  
Smoking 
26. When last did you smoke a cigarette? 
 a. More than two years ago or NEVER  
 b. One to two years ago 
 c. Four to twelve months ago 
 d. One to three months ago  
 e. Within the last month  
 f. Today  
27. If you have smoked (even one puff) within the LAST SEVEN DAYS how many 
cigarettes did you smoke on an average day? (number of cigarettes) _________ 
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  Alcohol 
28. When last did you have a drink containing alcohol? 
 a. More than two years ago or NEVER  
 b. One to two years ago 
 c. Four to twelve months ago 
 d. One to three months ago  
 e. Within the last month  
 f. Within the last week  
i. If within the last week, on how many days within the LAST 
SEVEN DAYS did you have a drink containing alcohol? 
0 1 2 3  4  5  6  7 
29. If you consume alcohol, what type of alcohol do you usually consume? (check all 
relevant options) 
 a. Beer  
 b. Wine  
 c. Spirit  
 d. Other (specify) ___________________________________ 
 e. I don’t drink any alcohol  
 
Weight status 
30. Body Mass Index 
a. What is your body weight (in kilograms)?  __________ 
b. What is your height (in meters)?  _____________ 
c. BMI calculation ______________ 
31. What is your waist circumference (in cm)?  ____________ 
 
Diet 
32. How many of the LAST SEVEN DAYS did you follow a healthful eating plan? 
0 1 2 3  4  5  6  7 
33. On average in the past month, how many days per week did you follow your eating 
plan? 
 0 1 2 3  4  5  6  7 
34. On how many of the LAST SEVEN DAYS did you eat at least five portions / 
servings of fruit and vegetables? 
0 1 2 3  4  5  6  7      
35. On how many of the LAST SEVEN DAYS did you eat high fat foods such as red 
meats and full cream dairy foods? 
 0 1 2 3  4  5  6  7 
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36. On how many of the LAST SEVEN DAYS did you consume sugar, sugar containing 
foods (such as desserts) or sugar sweetened beverages (such as carbonated drinks / 
sweetened tea or coffee)? 
0 1 2 3  4  5  6  7      
37. On how many of the LAST SEVEN DAYS did you space carbohydrates evenly 
through the day?  
0 1 2 3  4  5  6  7 
 
Medication 
38. On how many of the LAST SEVEN DAYS did you take your recommended diabetes 
medication?  
0 1 2 3  4  5  6  7 
 
Blood sugar testing 
39. On how many of the LAST SEVEN DAYS did you test your blood sugar? 
 0 1 2 3  4  5  6  7 
40. On how many of the LAST SEVEN DAYS did you test your blood sugar the number 
of times suggested by your health care provider?  
0 1 2 3  4  5  6  7 
 
Foot care  
41. On how many of the LAST SEVEN DAYS did you check your feet?  
0 1 2 3  4  5  6  7 
42. On how many of the LAST SEVEN DAYS have you washed your feet with warm 
water and mild soap? 
0 1 2 3  4  5  6  7 
43. On how many of the LAST SEVEN DAYS have you dried in-between your toes after 
washing or bathing? 
0 1 2 3  4  5  6  7      
44. On how many of the LAST SEVEN DAYS did you check the insides of your shoes? 
0 1 2 3  4  5  6  7 
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F. Healthcare Provider Related variables 
Concerning your index/current visit to this health facility: 
45. How many minutes did you spend with the doctor in the consulting room? _______ 
46. How many minutes did you spend at the pharmacy while waiting for your drugs to be 
dispensed? ___________ 
47. Were you reminded through any means (email, phone calls, letters etc.) by your 
healthcare provider about your follow up? 
 0. No 
 1. Yes 
48. What is your level of satisfaction regarding the services rendered by your diabetes 
management team? 
 a. Very satisfied 
 b. Satisfied 
 c. Dissatisfied 
 d. Very Dissatisfied 
49. Concerning dietary counselling, which of the following has your healthcare team 
(doctor, nurse, dietician or diabetes educator) advised you to do? (please check all 
that apply) 
 a.  Follow a low fat eating plan  
 b. Follow a complex carbohydrate eating plan 
 c. Reduce number of calories to lose weight 
 d. Eat lots of fibre rich foods 
 e. Other (specify) _____________________________________________ 
 f. I have not been given any advice about diet by my healthcare team 
50. Concerning physical activity, which of the following has your healthcare team 
(doctor, nurse, dietician or diabetes educator) advised you to do? (please check all 
that apply) 
 a. Get low level exercise (such as walking) on a daily basis 
 b. Exercise continuously for a least 20 minutes at least 3 times a week 
 c. Fit exercise into your daily routine (for example, take stairs instead of 
elevators, park a block away and walk, etc.) 
 d. Engage in a specific amount, type, duration and level of exercise. 
 e. Other (specify) _____________________________________________ 
 f. I have not been given any advice about exercise by my healthcare team 
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51. Concerning blood sugar testing, which of the following has your healthcare team 
(doctor, nurse, dietician or diabetes educator) advised you to do? (please check all 
that apply) 
 a. Test your blood sugar using a drop of blood from your finger and a 
color chart 
 b. Test your blood sugar using a machine to read the results 
 c. Test your urine for sugar 
 d. Other (specify) ____________________________________________ 
 e. I have not been given any advice about testing my blood or urine sugar 
level by my healthcare team 
52. Which of the following medications for your diabetes has your doctor prescribed? 
(Please check all that apply) 
 a. An insulin shot 1 or 2 times a day 
 b. An insulin shot 3 or more times a day 
 c. Diabetes pills to control my blood sugar level. 
 d. Other (specify): ________________________________________ 
 e. I have not been prescribed either insulin or pills for my diabetes 
53. Has any member of your healthcare team asked you about your smoking status? 
 0. No 
 1. Yes 
54. If you smoke, at your last doctor’s visit (or in the index/current visit), has anyone 
counselled you about stopping smoking or offered to refer you to a stop-smoking 
program? 
 0. No 
 1. Yes 
 2. Do not smoke 
  
http://etd.uwc.ac.za
91 
 
G. Complications 
55. Have you suffered from or are you suffering from any of these complications of 
diabetes? (Please check all that apply) 
 a. Eye Problem (Retinopathy) 
 b. Kidney Problem (Nephropathy) 
 c. Foot Ulcer/Amputation 
 d. Stroke 
 e. Myocardial Infarction 
 f. Abnormal sensations (Neuropathy) 
 g. Other (specify):  
____________________________________________________________ 
____________________________________________________________  
Thank you for your time and participation 
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Appendix 6 
 
